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Abstract
Background: Dignity therapy is psychotherapy to relieve psychological and existential distress in patients at the end of life. Little is 
known about its effect.
Aim: To analyse the outcomes of dignity therapy in patients with advanced life-threatening diseases.
Design: Systematic review was conducted. Three authors extracted data of the articles and evaluated quality using Critical Appraisal 
Skills Programme. Data were synthesized, considering study objectives.
Data sources: PubMed, CINAHL, Cochrane Library and PsycINFO. The years searched were 2002 (year of dignity therapy 
development) to January 2016. ‘Dignity therapy’ was used as search term. Studies with patients with advanced life-threatening 
diseases were included.
Results: Of 121 studies, 28 were included. Quality of studies is high. Results were grouped into effectiveness, satisfaction, suitability 
and feasibility, and adaptability to different diseases and cultures. Two of five randomized control trials applied dignity therapy to 
patients with high levels of baseline psychological distress. One showed statistically significant decrease on patients’ anxiety and 
depression scores over time. The other showed statistical decrease on anxiety scores pre–post dignity therapy, not on depression. 
Nonrandomized studies suggested statistically significant improvements in existential and psychosocial measurements. Patients, 
relatives and professionals perceived it improved end-of-life experience.
Conclusion: Evidence suggests that dignity therapy is beneficial. One randomized controlled trial with patients with high levels of 
psychological distress shows DT efficacy in anxiety and depression scores. Other design studies report beneficial outcomes in terms 
of end-of-life experience. Further research should understand how dignity therapy functions to establish a means for measuring its 
impact and assessing whether high level of distress patients can benefit most from this therapy.
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Review Article
What is already known about the topic?
•• DT was recently developed to relieve psychological and existential distress in patients at end of life. Originally was 
conceived for patients with low levels of distress.
•• DT seems to affect several dimensions of patients but the process and the way of measuring the impact of the inter-
vention are not clear.
What this paper adds?
•• This paper provides a critical and comprehensive view about DT including primary and secondary study results, which 
is key to have an overview of the therapy.
2 Palliative Medicine 
Background
Recent years have seen significant progress towards con-
trolling physical symptoms associated with advanced dis-
ease, but when it comes to related emotional aspects and 
addressing patients’ psychosocial and spiritual difficulties 
progress has been less obvious.1
As a disease progresses and the end approaches, emo-
tional suffering increases and patients’ sense of dignity is 
easily shaken.2 In this context, Chochinov2 developed in 
2002 dignity therapy (DT), a brief psychotherapy based on 
an empirical model of dignity that begins with reflection on 
why some patients with advanced disease wish to die, while 
others find serenity and a desire to enjoy their last days.
DT is a brief, individualized psychotherapy and aims to 
relieve psycho-emotional and existential distress and to 
improve the experiences of patients whose lives are threat-
ened by illness. This therapy offers patients an opportunity 
to reflect on issues that are important to them or other 
things that they would like to recall or transmit to others.
This psychotherapy’s protocol begins giving to the 
patient nine standard questions which are options for the 
patients’ consideration and reflection about what they want 
to say (Figure 1). The questions will guide a conversation 
with a DT-trained healthcare professional. Patients are 
given the questions in advance in order to familiarize 
themselves with the possibilities DT provides in terms of 
broaching areas they may wish to discuss. The session is 
recorded, transcribed and edited, after which a legacy doc-
ument is produced and delivered to the patient.
DT stands out for its simplicity and for its ability to 
enhance the meaning, direction and dignity of life for 
patients and their families.3 There is no evidence in how 
DT really works. There is lack of a comprehensive per-
spective of the different stakeholders who participate in 
the process (patient, family and health professionals) and 
of the cultural context. This article presents a comprehen-
sive systematic literature review of studies in which DT 
has been used for patients with life-threatening diseases.
Design
A comprehensive systematic review4 using PRISMA 
guideline was conducted.5
Search strategy
A sensitive search looking for articles, published in English 
and Spanish between January 2002 and January 2016, 
including the term ‘DT’ was carried out in PubMed (n = 49 
articles), CINAHL (n = 30 articles), Cochrane Library 
(n = 15 articles) and PsycINFO (n = 25 articles) (Figure 2). 
Additional studies were identified by contacting experts in 
DT and searching bibliographies.
Selection criteria
The inclusion criteria were as follows: DT studies in 
patients with advanced life-threatening diseases, regard-
less of the design. Editorials, commentaries and publica-
tions on research protocols were excluded. Articles were 
first selected on the basis of title and abstract and then fil-
tered after reading the complete article. Disagreements 
between reviewers were resolved by consensus among 
four researchers.
Data collection and analysis process
Independent data extraction from articles was made by 
three authors using predefined data template (aim, type of 
study, sample, data collection, results). The quality of arti-
cles was evaluated through the tools developed by Critical 
Appraisal Skills Programme (CASP) to read and check 
critically health research. These tools consist of checklists 
with screening questions and hints to assess and interpret 
articles’ quality considering methodological issues.6
Data were synthesized, considering the studies’ objec-
tives and the results, and are presented in thematic areas.
Results
In total, 121 articles were identified. After removing dupli-
cates and the title and abstract screening, 28 articles were 
included. All but five articles7–11 scored above 7/10 with 
the CASP critical reading process (Table 1). The studies 
included were conducted in the United Kingdom (n = 7), 
the United States (n = 5), Canada (n = 4), Australia (n = 3), 
Denmark (n = 2), Portugal (n = 3), Sweden (n = 1), Japan 
(n = 2) and Spain (n = 2).
•• This review offers for the first time the vision of all the participants in the process: patients, relatives and health 
professionals, showing that they are satisfied and would recommend DT as they find it helpful and useful.
•• This paper points out that DT might be more beneficial for patients with high levels of distress, a group population 
where initially DT was not recommended.
Implications for practice, theory or policy
•• The literature suggest benefits from DT for end of life patients as patients, families and health professionals found it 
helpful and are satisfied with the intervention.
•• Patients with high levels of distress seem to benefit more from DT, for that reason further research is needed to 
prove this.
•• Evidence suggests that DT can be adapted for patients with moto neurone disease and for the elderly.
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Dignity Psychotherapy Question Protocol
1.  Tell me a little about your life history; particularly the parts that you either remember most or think are the 
most important? When did you feel most alive?
2.  Are there specific things that you would want your family to know about you, and are there particular things 
you would want them to remember?
3.  What are the most important roles you have played in life (family roles, vocational roles, community-service 
roles, etc.)? Why were they so important to you and what do you think you accomplished in those roles?
4. What are your most important accomplishments and what do you feel most proud of?
5.  Are there particular things that you feel still need to be said to your loved ones or things that you would want to 
take the time to say once again?
6. What are your hopes and dreams for your loved ones?
7.  What have you learned about life that you would want to pass along to others? What advice or words of 
guidance would you wish to pass along to your son, daughter, husband, wife, parents, other(s)?
8.  Are there words or perhaps even instructions that you would like to offer your family to help prepare them for 
the future?
9. In creating this permanent record, are there other things that you would like to include?
Figure 1. Dignity psychotherapy question protocol.
Figure 2. Flow diagram of systematic review process.
4 Palliative Medicine 
The results are grouped on effectiveness of DT, satis-
faction, suitability and feasibility, adaptation to other cul-
tures and populations, and each article’s contribution to the 
various themes is shown in Table 1.
Effectiveness of DT
Clinical trials. Five randomized studies were 
identified.11,15,16,19,24,29,33 Chochinov’s group conducted the 
first randomized study on DT with 441 patients receiving 
palliative care (PC) with advanced disease and a life 
expectancy equal to or less than 6 months.15 Their research 
aimed to determine whether or not DT (n = 108) is better 
than standard PC (n = 111) and client-centred care (CCC) 
(n = 107) in terms of reducing psychological, existential, 
and spiritual distress. CCC is a type of psychotherapeutic 
support approach that focuses on non-generativity themes, 
that is, on here-and-now issues. Different measurements 
were implemented at the beginning and at the completion 
of the intervention: the Functional Assessment of Chronic 
Illness Therapy–Spiritual well-being (FACIT-Sp), a scale 
that evaluates spiritual well-being; the Patient Dignity 
Inventory (PDI), to evaluate distress related to patient dig-
nity and the Hospital Anxiety and Depression Scale 
(HADS), to evaluate anxiety and depression in the hospital 
setting. In addition, two quality-of-life measurements, the 
Edmonton Symptom Assessment Scale (ESAS) and a 
scale that measures the will to live, were used.
They found that patients who participated in the study 
had low baseline levels of distress, assessed by HADS. 
The post-intervention scores showed DT group had 
decreased depression scores and increased anxiety scores 
although these were not significant15 (Table 2).
Another randomized clinical trial aimed to assess DT’s 
potential effectiveness in reducing distress in advanced 
cancer patients (n = 45) referred to PC teams.16 While no 
part of the DT protocol, this study included interest in dig-
nity as an entry criteria for patients offered DT. The inter-
vention group received DT and standard PC (n = 22) and 
the control group standard PC alone (n = 23).
Different outcomes were evaluated at the baseline and 1 
and 4 weeks after the ‘generativity’ document was deliv-
ered: PDI, the Herth Hope Index (HHI) for measuring 
sense of hope, HADS, EQ-5D and a satisfaction 
Table 1. Articles by thematic area and CASP score.
Article Effectiveness Suitability/feasibility Satisfaction Adaptation CASP score
Passik et al.12  8
Chochinov et al.13  8.5
McClement et al.7  6
Houman et al.14  7
Chochinov et al.15  8
Hall et al.16   9
Montross et al.17   7
Akechi et al.8    5
Chochinov et al.18  9
Hall et al.19   8
Goddard et al.20  8
Hall et al.21  7
Hall et al.22  7
Hall et al.23   8
Johns et al.9  6
Juliao et al.24  8
Montross et al.25   7
Bentley et al.26     8
Bentley et al.27     8
Houmann et al.28  9
Javaloyes et al.10  4
Juliao et al.29  9
Vergo et al.30   7
Aoun et al.31     9
Johnston et al.32  7
Juliao et al.33  9
Lindquist et al.34   7
Rudilla et al.11  6
CASP: Critical Appraisal Skills Programme.6
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 in
 
pa
tie
nt
s 
w
ith
 a
dv
an
ce
d 
ca
nc
er
.
R
C
T
T
w
o 
gr
ou
ps
: D
T
 
ve
rs
us
 D
T
 s
ta
nd
ar
d 
pa
lli
at
iv
e 
ca
re
.
C
an
ce
r 
pa
tie
nt
s 
(N
 =
 4
5)
D
T
 (
in
te
rv
en
tio
n;
 n
 =
 2
2)
St
an
da
rd
 c
ar
e 
(c
on
tr
ol
; n
 =
 2
3)
D
at
a 
co
lle
ct
io
n 
in
 fa
ce
-t
o-
fa
ce
 
in
te
rv
ie
w
s 
be
fo
re
 t
he
 s
tu
dy
 (
T0
), 
a 
w
ee
k 
(T
1)
 a
nd
 4
 w
ee
ks
 (
T2
) 
af
te
r 
D
T
: P
D
I.
Se
co
nd
ar
y 
ou
tc
om
e:
H
H
I.
H
A
D
S.
Q
ua
lit
y 
of
 li
fe
 (
EQ
-5
D
).
Li
ke
rt
 s
ca
le
.
D
T
PF
Q
.
PD
I:
C
on
tr
ol
: T
0 
=
 4
6.
13
, T
1 
=
 3
9.
40
, T
2 
=
 4
2.
10
.
In
te
rv
en
tio
n:
 T
0 
=
 4
3.
00
; T
1 
=
 4
2.
00
, T
2 
=
 4
3.
63
.
H
op
e:
C
on
tr
ol
: T
0 
=
 3
7.
35
; T
1 
=
 3
5.
87
; T
2 
=
 3
5.
30
.
In
te
rv
en
tio
n:
 T
0 
=
 3
7.
09
, T
1 
=
 3
8.
00
, T
2 
=
 3
7.
50
.
O
nl
y 
di
ffe
re
nc
e 
at
 T
1 
in
 h
op
e:
 x–
=
2.
55
 (
95
%
 C
I: 
−
4.
73
 t
o 
−
0.
36
, p
 =
 0
.0
2)
D
T 
ve
rs
us
 C
on
tr
ol
 a
t 4
 w
ee
ks
:
H
el
pf
ul
: x–
=
0.
63
 (
95
%
 C
I: 
−
1.
22
 t
o 
−
0.
04
; p
 =
 0
.0
4)
.
Se
ns
e 
of
 p
ur
po
se
: x–
=
1.
16
 (
95
%
 C
I: 
−
2.
08
 t
o 
−
0.
24
; p
 =
 0
.0
2)
.
M
ea
ni
ng
: x–
=
0.
85
 (
95
%
 C
I: 
−
1.
78
 t
o 
0.
09
; p
 =
 0
.0
7)
.
Fa
m
ily
 s
up
po
rt
: x–
=
1.
07
 (
95
%
 C
I: 
−
2.
22
 t
o 
0.
08
; p
 =
 0
.0
7)
.
M
on
tr
os
s 
et
 a
l.1
7  
(2
01
1)
, U
SA
Pr
ov
id
e 
pr
ac
tic
al
 in
fo
rm
at
io
n 
ab
ou
t 
em
pl
oy
in
g 
D
T
 in
 
ho
sp
ic
e.
Q
ua
lit
at
iv
e 
st
ud
y
C
om
m
un
ity
-b
as
ed
 h
os
pi
ce
 
pa
tie
nt
s 
(N
 =
 2
7)
.
In
te
rv
ie
w
s.
Pa
tie
nt
s 
ta
lk
ed
 a
bo
ut
 a
ut
ob
io
gr
ap
hi
ca
l i
nf
or
m
at
io
n,
 lo
ve
 a
nd
 li
fe
 le
ss
on
s 
an
d 
ac
co
m
pl
is
hm
en
ts
.
R
an
ge
 c
os
t 
fo
r 
pa
tie
nt
s’
 t
ra
ns
cr
ip
ts
: U
S$
27
.0
0–
U
S$
14
3.
75
.
A
ke
ch
i e
t 
al
.8  
(2
01
2)
, J
ap
an
Ev
al
ua
te
 t
he
 fe
as
ib
ili
ty
 o
f D
T
 
in
 t
he
 Ja
pa
ne
se
 p
op
ul
at
io
n.
T
ra
ns
ve
rs
al
 s
tu
dy
.
O
ne
 h
os
pi
ce
 a
nd
 t
w
o 
ho
sp
ita
ls
.
A
du
lt 
ad
va
nc
ed
 c
an
ce
r 
pa
tie
nt
s 
(N
 =
 1
1)
.
Pa
rt
ic
ip
at
io
n 
ra
te
 o
f t
he
 e
lig
ib
le
 
pa
tie
nt
s.
C
om
pl
et
io
n 
ra
te
 o
f p
ar
tic
ip
an
ts
 
D
T
PF
Q
.
86
%
 r
ef
us
al
 r
at
e.
D
T 
pa
rt
ici
pa
nt
s’ 
se
lf-
re
po
rt
: 6
7%
 u
se
fu
ln
es
s 
fo
r 
im
pr
ov
in
g 
di
gn
ity
.
56
%
 b
en
ef
ic
ia
l, 
im
pr
ov
em
en
t i
n 
m
ea
ni
ng
 a
nd
 u
se
fu
ln
es
s 
fo
r 
se
ns
e 
of
 w
el
l-b
ei
ng
.
78
%
 h
el
pf
ul
 fo
r 
fa
m
ily
.
C
ho
ch
in
ov
 e
t 
al
.18
 
(2
01
2)
, C
an
ad
a
Ev
al
ua
te
 t
he
 fe
as
ib
ili
ty
 o
f D
T
 
in
 t
he
 e
ld
er
ly
.
T
ra
ns
ve
rs
al
 s
tu
dy
.
12
 c
og
ni
tiv
el
y 
in
ta
ct
 a
nd
 1
1 
co
gn
iti
ve
ly
 im
pa
ir
ed
, f
ra
il 
el
de
rl
y 
pe
op
le
 in
 lo
ng
-t
er
m
 c
ar
e.
24
 r
el
at
iv
es
.
12
 h
ea
lth
 c
ar
e 
pr
ov
id
er
s 
(H
PC
).
Ex
am
in
at
io
n 
of
 p
ro
m
in
en
t 
th
em
es
 
th
at
 e
m
er
ge
d 
fr
om
 t
ra
ns
cr
ib
ed
 D
T
 
na
rr
at
iv
es
.
Fa
m
ily
 p
ro
xi
es
: a
 m
od
ifi
ed
 p
os
t-
in
te
rv
en
tio
n 
fe
ed
ba
ck
 q
ue
st
io
nn
ai
re
 
an
d 
a 
fe
ed
ba
ck
 q
ue
st
io
nn
ai
re
 
2 
m
on
th
s 
po
st
-in
te
rv
en
tio
n.
H
ea
lth
 p
ro
fe
ss
io
na
ls
 (
H
P)
: 
qu
es
tio
nn
ai
re
 2
 m
on
th
s 
po
st
-
in
te
rv
en
tio
n.
C
og
ni
tiv
el
y 
in
ta
ct
 r
es
id
en
ts
: 9
 fo
un
d 
D
T 
he
lp
fu
l a
nd
 h
al
f u
se
fu
l f
or
 th
ei
r 
fa
m
ili
es
.
D
T 
he
lp
fu
l f
or
 r
es
id
en
ts
:
Fa
m
ili
es
 o
f c
og
ni
tiv
el
y 
in
ta
ct
 p
at
ie
nt
s:
 4
/5
.
Fa
m
ili
es
 o
f c
og
ni
tiv
el
y 
im
pa
ir
ed
: 0
/9
.
D
T 
im
po
rt
an
t c
om
po
ne
nt
 o
f r
es
id
en
ts
’ c
ar
e:
Fa
m
ili
es
 o
f c
og
ni
tiv
el
y 
in
ta
ct
 p
at
ie
nt
s:
 3
/5
.
Fa
m
ili
es
 o
f c
og
ni
tiv
el
y 
im
pa
ir
ed
: 3
/9
.
H
PC
 v
al
ue
 fo
r 
th
em
se
lve
s:
H
el
p 
pr
ov
id
e 
ca
re
 t
o 
im
pa
ir
ed
 r
es
id
en
ts
: 5
/7
 H
P.
H
el
p 
ap
pr
ec
ia
te
 im
pa
ir
ed
 r
es
id
en
t: 
6/
7 
H
P.
H
el
p 
pr
ov
id
e 
ca
re
 t
o 
co
gn
iti
ve
 in
ta
ct
 r
es
id
en
ts
: 4
/7
 H
P.
H
el
p 
ap
pr
ec
ia
te
 c
og
ni
tiv
e 
in
ta
ct
 r
es
id
en
t: 
6/
7 
H
P.
H
al
l e
t 
al
.19
 
(2
01
2)
, U
K
Ev
al
ua
te
 t
he
 a
cc
ep
ta
bi
lit
y,
 
ef
fe
ct
iv
en
es
s 
an
d 
ad
ap
ta
bi
lit
y 
of
 D
T
 t
o 
re
du
ce
 p
at
ie
nt
s’
 
di
st
re
ss
 in
 n
ur
si
ng
 h
om
es
.
R
C
T
.
O
ld
er
 p
eo
pl
e 
liv
in
g 
in
 n
ur
si
ng
 
ho
m
es
 w
ith
 n
o 
m
aj
or
 c
og
ni
tiv
e 
im
pa
ir
m
en
t 
(N
 =
 6
0)
.
C
on
tr
ol
 g
ro
up
 (
n 
=
 2
9)
: s
ta
nd
ar
d 
ps
yc
ho
lo
gi
ca
l a
nd
 s
pi
ri
tu
al
 c
ar
e.
In
te
rv
en
tio
n 
gr
ou
p 
(n
 =
 3
1)
: D
T
 
+
 s
ta
nd
ar
d 
ca
re
.
Ba
se
lin
e 
de
m
og
ra
ph
ic
 d
at
a:
Bl
es
se
d 
O
rie
nt
at
io
n 
M
em
or
y 
C
on
ce
nt
ra
tio
n 
te
st
, K
ar
no
fs
ky
 s
co
re
s, 
Ba
rt
he
l a
ge
, g
en
de
r, 
et
hn
ic
 g
ro
up
.
Fa
ce
-t
o-
fa
ce
 d
at
a 
co
lle
ct
io
n 
at
 
ba
se
lin
e 
(T
1)
, a
t 
1 
w
ee
k 
(T
2)
 a
nd
 
8 
w
ee
ks
 (
T3
) 
fo
llo
w
-u
p:
PD
I.
G
D
S.
H
er
th
 H
op
e 
In
de
x.
Q
ua
lit
y 
of
 li
fe
 (
EQ
-5
D
).
2 
ite
m
s 
fo
r 
m
ea
su
re
 o
f q
ua
lit
y 
of
 li
fe
.
Fe
as
ib
ili
ty
 m
ea
su
re
s:
 n
um
be
r 
of
 
vi
si
ts
, t
he
ra
py
 d
ur
at
io
n 
an
d 
so
 o
n.
A
cc
ep
ta
bi
lit
y 
of
 D
T
 m
ea
su
re
: 
ra
nk
in
g 
w
he
th
er
 p
ar
tic
ip
at
in
g 
in
 
D
T
 o
r 
in
 t
he
 s
tu
dy
 (
co
nt
ro
l g
ro
up
) 
he
lp
ed
 t
he
m
 o
r 
th
ei
r 
fa
m
ily
.
In
te
rv
ie
w
ed
 r
ec
ip
ie
nt
s 
of
 
‘g
en
er
at
iv
ity
’ d
oc
um
en
ts
.
PD
I:
T0
: C
 =
 4
1.
75
; I
 =
 3
9.
00
; p
 =
 0
.3
9.
T1
: C
 =
 4
2.
44
; I
 =
 4
0.
22
; p
 =
 0
.5
3.
T2
: C
 =
 3
5.
29
; I
 =
 3
4.
93
; p
 =
 0
.6
4.
M
ea
ni
ng
 in
 li
fe
:
T1
: C
 =
 3
.5
0;
 I 
=
 4
.0
0;
 p
 =
 0
.0
4.
T2
: C
 =
 3
.7
6;
 I 
=
 4
.0
0;
 p
 =
 0
.4
9.
H
el
p 
th
ei
r 
fa
m
ilie
s:
T1
: C
 =
 3
.1
6;
 I 
=
 3
.8
2;
 p
 =
 0
.0
2.
T2
: C
 =
 3
.0
0;
 I 
=
 4
.0
0;
 p
 =
 0
.0
1.
T
ab
le
 2
. 
(C
on
tin
ue
d)
Martínez et al. 7
 (C
on
tin
ue
d)
A
ut
ho
r 
(y
ea
r)
, 
co
un
tr
y
M
ai
n 
ob
je
ct
iv
e
T
yp
e 
of
 s
tu
dy
Sa
m
pl
e
D
at
a 
co
lle
ct
io
n
M
ai
n 
re
su
lts
G
od
da
rd
 e
t 
al
.20
 
(2
01
3)
, U
K
Ex
pl
or
e 
pa
tie
nt
s’
 
ex
pe
ri
en
ce
s 
in
 n
ur
si
ng
 
ho
m
es
 (
C
H
) 
w
he
re
 D
T
 is
 
us
ed
 fr
om
 t
he
 p
oi
nt
 o
f v
ie
w
 
of
 t
he
 fa
m
ily
.
Q
ua
si
-e
xp
er
im
en
ta
l 
st
ud
y.
Fa
m
ili
es
 t
ha
t 
re
ce
iv
ed
 t
he
 
tr
an
sc
ri
be
d 
do
cu
m
en
t 
(N
 =
 1
4)
.
Se
m
i-s
tr
uc
tu
re
d 
te
le
ph
on
e 
or
 in
-
pe
rs
on
 in
te
rv
ie
w
s.
Fa
m
ily
 p
oi
nt
 o
f v
ie
w
:
T
he
 d
oc
um
en
t: 
Pa
rt
ic
ip
an
ts
 w
er
e 
sa
tis
fie
d 
an
d 
gr
at
ef
ul
 fo
r 
m
ak
in
g 
it.
Im
pa
ct
 o
n 
re
si
de
nt
s:
 P
os
iti
ve
 a
ss
es
sm
en
t 
of
 in
te
ra
ct
io
n 
w
ith
 t
he
 t
he
ra
pi
st
.
Im
pa
ct
 o
n 
th
e 
fa
m
ily
: o
pp
or
tu
ni
ty
 t
o 
le
ar
n 
m
or
e 
ab
ou
t 
th
e 
pa
tie
nt
 a
nd
 t
o 
en
co
ur
ag
e 
co
m
m
un
ic
at
io
n 
w
as
 p
os
iti
ve
.
Im
pa
ct
 o
n 
C
H
s:
 d
oc
um
en
t 
im
pr
ov
es
 t
he
 c
ar
eg
iv
er
–p
at
ie
nt
 r
el
at
io
ns
hi
p.
D
T
 b
en
ef
its
 p
at
ie
nt
s’
 e
nd
-o
f-l
ife
 e
xp
er
ie
nc
e,
 a
s 
w
el
l a
s 
th
at
 o
f t
he
ir
 
fa
m
ili
es
, a
nd
 t
he
y 
w
ou
ld
 r
ec
om
m
en
d 
it.
C
og
ni
tiv
e 
im
pa
ir
m
en
t 
re
qu
ir
es
 t
ho
se
 w
ho
 a
dm
in
is
te
r 
D
T
 t
o 
co
ns
id
er
 
w
ho
 w
ou
ld
 b
en
ef
it 
fr
om
 it
 a
nd
 t
he
 n
ee
d 
to
 m
ak
e 
ch
an
ge
s 
to
 it
 b
ec
au
se
 o
f 
fa
m
ily
 in
vo
lv
em
en
t.
H
al
l e
t 
al
.21
 
(2
01
3)
, U
K
Ex
pl
or
e 
th
e 
im
pa
ct
 o
f D
T
 
in
 a
dv
an
ce
d 
ca
nc
er
 p
at
ie
nt
s 
w
ho
 s
uf
fe
r 
fr
om
 s
tr
es
s.
C
as
e 
st
ud
y 
ap
pr
oa
ch
, 
se
co
nd
ar
y 
an
al
ys
is
 
of
 q
ua
nt
ita
tiv
e 
an
d 
qu
al
ita
tiv
e 
da
ta
 fr
om
 
a 
m
ix
ed
-m
et
ho
ds
 
R
C
T
 fr
om
 t
hr
ee
 
pa
rt
ic
ip
an
ts
.
H
os
pi
ta
l-b
as
ed
 p
al
lia
tiv
e 
ca
re
 
te
am
s.
17
 p
at
ie
nt
s 
re
ce
iv
ed
 D
T
; 3
 w
ith
 
hi
gh
es
t 
di
gn
ity
-r
el
at
ed
 d
is
tr
es
s 
se
le
ct
ed
 fo
r 
th
e 
ca
se
 s
tu
di
es
.
O
ut
co
m
e 
m
ea
su
re
s 
co
lle
ct
ed
 in
 
fa
ce
-t
o-
fa
ce
 in
te
rv
ie
w
s 
at
 b
as
el
in
e,
 
at
 1
 a
nd
 4
 w
ee
ks
 p
os
t-
in
te
rv
en
tio
n:
PD
I.
R
at
in
g 
of
 p
er
ce
iv
ed
 b
en
ef
its
 o
f D
T
 
at
 c
om
pl
et
io
n 
an
d 
at
 fo
llo
w
-u
ps
.
Q
ua
lit
at
iv
e 
in
te
rv
ie
w
s 
ex
pl
or
in
g 
pa
tie
nt
s’
 v
ie
w
s 
of
 D
T
 a
nd
 t
ho
se
 
w
ho
 r
ec
ei
ve
d 
ge
ne
ra
tiv
ity
 
do
cu
m
en
ts
.
A
ll 
th
ou
gh
t 
th
at
 D
T
 h
ad
 h
el
pe
d 
th
em
 a
nd
 w
ou
ld
 h
el
p 
th
ei
r 
fa
m
ili
es
.
PD
I:
Be
ve
rl
ey
: T
1 
=
 9
4,
 T
2 
=
 6
5,
 T
3 
=
 8
0.
Ev
e:
 T
1 
=
 6
5,
 T
2 
=
 5
0,
 T
3 
=
 6
1.
Sh
ei
la
: T
1 
=
 6
2,
 T
2 
=
 7
5,
 T
3 
=
 5
2.
H
al
l e
t 
al
.22
 
(2
01
3)
, U
K
Ex
pl
or
e 
an
d 
co
m
pa
re
 
pa
rt
ic
ip
an
ts
’ v
ie
w
s 
on
 t
ak
in
g 
pa
rt
 in
 r
an
do
m
iz
ed
 D
T
 
st
ud
y.
Q
ua
lit
at
iv
e 
pa
rt
 o
f a
 
bi
gg
er
 R
C
T
 s
tu
dy
 (
H
al
l 
et
 a
l.,
 2
01
2)
.
El
de
rl
y 
re
si
de
nt
s 
w
ith
 n
o 
co
gn
iti
ve
 im
pa
ir
m
en
t 
liv
in
g 
in
 o
ne
 o
f t
he
 1
5 
ca
re
 h
om
es
 
(N
 =
 4
9)
.
In
te
rv
en
tio
n 
(D
T
) 
(n
 =
 2
5)
C
on
tr
ol
 (
n 
=
 2
4)
.
Se
e 
H
al
l e
t 
al
.19
 (
20
12
)
A
ll 
re
si
de
nt
s 
st
ill
 in
 t
he
 s
tu
dy
 a
t 
fo
llo
w
-u
p 
w
er
e 
in
te
rv
ie
w
ed
.
Fa
ce
-t
o-
fa
ce
 s
em
i-s
tr
uc
tu
re
d 
in
te
rv
ie
w
s 
at
 1
 w
ee
k 
(2
5/
29
 c
on
tr
ol
 
gr
ou
p 
an
d 
24
/3
1 
in
te
rv
en
tio
n 
gr
ou
p)
 a
nd
 8
 w
ee
ks
 (
21
 c
on
tr
ol
 
gr
ou
p 
an
d 
24
/1
5 
in
te
rv
en
tio
n 
gr
ou
p)
 a
bo
ut
 v
ie
w
s 
on
 t
he
 t
he
ra
py
 
an
d/
or
 t
ak
in
g 
pa
rt
 in
 t
he
 s
tu
dy
.
In
te
rv
ie
w
er
 d
iff
er
en
t 
fr
om
 t
he
 
th
er
ap
is
t.
Fr
am
ew
or
k 
an
al
ys
is
.
U
ni
qu
e 
th
em
es
 in
 t
he
 in
te
rv
en
tio
n 
gr
ou
p:
 v
ie
w
s 
on
 t
he
 g
en
er
at
iv
ity
 
do
cu
m
en
t, 
ge
ne
ra
tiv
ity
 a
nd
 r
em
in
is
ce
nc
e.
Si
x 
th
em
es
 e
m
er
ge
d 
in
 b
ot
h 
gr
ou
ps
: r
ef
oc
us
in
g,
 m
ak
in
g 
a 
co
nt
ri
bu
tio
n,
 
in
te
ra
ct
io
n 
w
ith
 t
he
 r
es
ea
rc
he
r 
or
 t
he
ra
pi
st
, d
iv
er
si
on
 a
nd
 n
ot
 h
el
pi
ng
 
w
ith
 t
he
ir
 p
ro
bl
em
s 
an
d 
co
gn
iti
ve
 im
pa
ir
m
en
t.
St
ud
y 
de
sc
ri
be
s 
be
ne
fit
s 
of
 t
he
 D
T
, s
om
e 
di
ffi
cu
lti
es
 r
eg
ar
di
ng
 p
at
ie
nt
 
co
gn
iti
ve
 im
pa
ir
m
en
t 
w
er
e 
ob
se
rv
ed
.
H
al
l e
t 
al
.23
 
(2
01
3)
, U
K
T
o 
ex
pl
or
e 
th
e 
vi
ew
s 
of
 
st
ud
y 
an
d 
co
nt
ro
l g
ro
up
 
pa
rt
ic
ip
an
ts
 c
on
ce
rn
in
g 
th
e 
be
ne
fit
s 
of
 t
ak
in
g 
pa
rt
 in
 D
T
.
Q
ua
lit
at
iv
e 
pa
rt
 o
f a
 
bi
gg
er
 R
C
T
 s
tu
dy
 (
H
al
l 
et
 a
l.,
 2
01
2)
.
45
 a
du
lt 
ca
nc
er
 p
at
ie
nt
s 
re
fe
rr
ed
 
to
 p
al
lia
tiv
e 
ca
re
 t
ea
m
s.
In
te
rv
en
tio
n 
(D
T
, n
 =
 2
2)
C
on
tr
ol
 (
n 
=
 2
3)
.
A
ll 
pa
rt
ic
ip
an
ts
 w
ho
 r
em
ai
ne
d 
in
 t
he
 s
tu
dy
 a
t 
fo
llo
w
-u
p 
w
er
e 
in
te
rv
ie
w
ed
. P
at
ie
nt
s 
in
te
rv
ie
w
ed
 
at
 t
he
 1
-w
ee
k 
(n
 =
 2
9)
 a
nd
 4
-w
ee
k 
fo
llo
w
-u
p 
(n
 =
 2
0)
.
In
te
rv
ie
w
s 
w
ith
 fa
m
ili
es
 (
n 
=
 9
) 
of
 
pa
tie
nt
s 
in
 D
T
 g
ro
up
.
Fr
am
ew
or
k 
an
al
ys
is
.
U
ni
qu
e 
th
em
e 
of
 D
T
 g
ro
up
: g
en
er
at
iv
ity
.
Pr
ev
al
en
t 
th
em
es
 in
 b
ot
h 
gr
ou
ps
 w
er
e 
ho
pe
fu
ln
es
s 
(p
ar
tic
ip
an
ts
: 6
 D
T
 v
s 
5 
co
nt
ro
l) 
an
d 
te
no
r 
of
 c
ar
e 
(p
ar
tic
ip
an
ts
: 6
 D
T
 v
s 
8 
co
nt
ro
l).
Pr
ev
al
en
t 
th
em
es
 in
 D
T
 g
ro
up
: p
se
ud
o 
lif
e 
re
vi
ew
 (
pa
rt
ic
ip
an
ts
: 9
 D
T
 v
s 
2 
co
nt
ro
l);
 r
em
in
is
ce
nc
e 
(p
ar
tic
ip
an
ts
: 8
 D
T
 v
s 
2 
co
nt
ro
l) 
an
d 
po
te
nt
ia
l 
im
pa
ct
 o
n 
re
la
tio
ns
hi
ps
 (
pa
rt
ic
ip
an
ts
: 5
 D
T
 v
s 
1 
co
nt
ro
l).
Pa
tie
nt
s 
an
d 
fa
m
ily
 m
em
be
rs
 e
xp
la
in
ed
 t
ha
t 
D
T
 w
as
 h
el
pf
ul
 fo
r 
th
em
.
T
ab
le
 2
. 
(C
on
tin
ue
d)
8 Palliative Medicine 
A
ut
ho
r 
(y
ea
r)
, 
co
un
tr
y
M
ai
n 
ob
je
ct
iv
e
T
yp
e 
of
 s
tu
dy
Sa
m
pl
e
D
at
a 
co
lle
ct
io
n
M
ai
n 
re
su
lts
Jo
hn
s 
et
 a
l.9
 
(2
01
3)
, U
SA
Ev
al
ua
te
 t
he
 fe
as
ib
ili
ty
 o
f 
ap
pl
yi
ng
 D
T
 in
 a
 u
ni
ve
rs
ity
-
ba
se
d 
ca
nc
er
 c
en
tr
e.
Pr
e-
 a
nd
 p
os
t-
in
te
rv
en
tio
n 
de
si
gn
.
Pa
tie
nt
s 
w
ith
 m
et
as
ta
tic
 c
an
ce
r 
in
 ju
st
 o
ne
 g
ro
up
 (
N
 =
 1
0)
.
Be
fo
re
 a
nd
 a
ft
er
 D
T
 (
1 
m
on
th
 a
ft
er
 
ha
nd
in
g 
D
T
 d
oc
um
en
t)
:
7-
ite
m
 c
an
ce
r 
di
st
re
ss
 m
ea
su
re
.
BD
I-I
I.
FA
C
IT
-P
A
L.
O
f t
he
 1
0 
in
iti
al
 p
ar
tic
ip
an
ts
, 4
 c
om
pl
et
ed
 t
he
 p
ro
ce
ss
. N
o 
st
at
is
tic
s 
w
er
e 
ob
ta
in
ed
.
An
xi
et
y:
Ba
se
lin
e 
D
T
: x–
 =
 2
.0
, S
D
 =
 1
.4
.
Po
st
-D
T
: x–
=
 3
.0
, S
D
 =
 2
.2
.
D
ep
re
ss
io
n:
Ba
se
lin
e 
D
T
: x–
 =
 1
0.
5,
 S
D
 =
 9
.7
.
Po
st
-D
T
: x–
 =
 1
3.
5,
 S
D
 =
 9
.0
.
Sa
tis
fa
ct
io
n 
su
rv
ey
:
H
el
pf
ul
 to
 p
at
ie
nt
:
Pa
tie
nt
 r
at
in
g:
 x–
 =
 3
.3
, S
D
 =
 1
.0
.
Fa
m
ily
 r
at
in
g:
 x–
 =
 3
.5
, S
D
 =
 0
.6
.
H
el
pf
ul
 to
 fa
m
ily
:
Pa
tie
nt
 r
at
in
g:
 x–
 =
 3
.0
, S
D
 =
 2
.0
.
Fa
m
ily
 r
at
in
g:
 x–
 =
 3
.2
, S
D
 =
 0
.4
.
Ju
lia
o 
et
 a
l.2
4  
(2
01
3)
, P
or
tu
ga
l
T
o 
de
te
rm
in
e 
D
T
’s
 in
flu
en
ce
 
on
 d
ep
re
ss
io
n 
sy
m
pt
om
s 
an
d 
an
xi
et
y 
in
 p
at
ie
nt
s 
w
ith
 
ad
va
nc
ed
 d
is
ea
se
.
R
C
T
.
Pa
rt
ic
ip
an
ts
 w
ith
 li
fe
-t
hr
ea
te
ni
ng
 
di
se
as
es
 (
N
 =
 6
0)
.
Sa
m
pl
e:
 t
w
o 
gr
ou
ps
:
In
te
rv
en
tio
n:
 D
T
 +
 P
SC
 (
n 
=
 2
9)
.
C
on
tr
ol
: P
SC
 (
n 
=
 3
1)
.
H
A
D
S 
at
 b
as
el
in
e 
(T
 =
 1
) 
an
d 
on
 
da
ys
 4
 (
T 
=
 2
), 
15
 (
T 
=
 3
) 
an
d 
30
 
(T
 =
 4
) 
af
te
r 
th
e 
in
te
rv
en
tio
n.
D
ep
re
ss
io
n,
 in
te
rv
en
tio
n 
ve
rs
us
 c
on
tr
ol
:
4 
da
ys
: x–
 =
 −
4.
46
 (
95
%
 C
I: 
−
6.
91
 t
o 
−
2.
02
; p
 =
 0
.0
01
).
15
 d
ay
s:
 x–
=
 −
3.
96
 (
95
%
 C
I =
 −
7.
33
 t
o 
−
0.
61
; p
 =
 0
.0
22
).
30
 d
ay
s:
 x–
=
 −
3.
33
 (
95
%
 C
I =
 −
7.
32
 t
o 
0.
65
; p
 =
 0
.0
97
).
An
xi
et
y,
 in
te
rv
en
tio
n 
ve
rs
us
 c
on
tr
ol
:
4 
da
ys
: x–
=
 −
3.
96
 (
95
%
 C
I =
 −
6.
66
 t
o 
−
1.
25
; p
 =
 0
.0
05
).
15
 d
ay
s:
 x–
 =
 −
6.
19
 (
95
%
 C
I =
 −
10
.4
9 
to
 −
1.
88
; p
 =
 0
.0
06
).
30
 d
ay
s:
 x–
 =
 −
5.
07
 (
95
%
 C
I =
 −
10
.2
2 
to
 0
.0
9;
 p
 =
 0
.0
54
).
M
on
tr
os
s 
et
 a
l.2
5  
(2
01
3)
, U
SA
Ex
pl
or
e 
he
al
th
ca
re
 
pr
of
es
si
on
al
s’
 (
H
P)
 
pe
rc
ep
tio
ns
 o
f D
T
.
T
ra
ns
ve
rs
al
.
In
te
rd
is
ci
pl
in
ar
y 
H
P 
(N
 =
 1
8)
.
In
di
vi
du
al
 in
te
rv
ie
w
s:
 r
at
in
gs
 t
o 
5 
qu
es
tio
ns
 +
 se
m
i-s
tr
uc
tu
re
d 
qu
es
tio
ns
.
Q
ua
nt
ita
tiv
e 
re
su
lts
:
D
T
 w
or
th
w
hi
le
: x–
 =
 3
.8
3,
 S
D
 =
 0
.3
9.
D
T
 r
ed
uc
ed
 p
ai
n 
an
d 
su
ffe
ri
ng
: x–
 =
 3
.4
2,
 S
D
 =
 0
.6
7.
D
T
 h
el
ps
 t
he
 fa
m
ily
 in
 t
he
 fu
tu
re
: 9
2%
.
H
Ps
 r
ec
om
m
en
d 
D
T
: 1
00
%
.
Q
ua
lit
at
ive
 r
es
ul
ts
:
83
%
 D
T
 o
pp
or
tu
ni
ty
 t
o 
sh
ar
e 
st
or
ie
s 
an
d 
le
ss
on
s 
w
as
 a
 p
os
iti
ve
 
ex
pe
ri
en
ce
 fo
r 
pa
tie
nt
s.
50
%
 D
T
 a
ffi
rm
ed
 t
he
ir
 b
el
ie
fs
 a
nd
 v
al
ue
s 
an
d 
pr
ov
id
ed
 m
ea
ni
ng
 in
 li
fe
.
78
%
 o
f h
ea
lth
ca
re
 p
ro
vi
de
rs
 t
ho
ug
ht
 t
he
 t
im
e 
it 
ta
ke
s 
to
 d
o 
D
T
 is
 a
n 
ad
de
d 
co
st
.
94
%
 b
el
ie
ve
d 
th
at
 t
he
 t
im
e 
w
as
 w
el
l s
pe
nt
.
Be
nt
le
y 
et
 a
l.2
6  
(2
01
4)
, A
us
tr
al
ia
T
o 
ev
al
ua
te
 t
he
 fe
as
ib
ili
ty
, 
ac
ce
pt
ab
ili
ty
 a
nd
 p
ot
en
tia
l 
ef
fe
ct
iv
en
es
s 
of
 D
T
 fo
r 
fa
m
ily
 c
ar
eg
iv
er
s 
of
 p
eo
pl
e 
w
ith
 m
ot
or
 n
eu
ro
n 
di
se
as
es
 
(A
LS
).
Pr
e–
po
st
 t
es
t 
de
si
gn
 
w
ith
 fa
m
ily
 c
ar
eg
iv
er
s 
of
 p
eo
pl
e 
di
ag
no
se
d 
w
ith
 A
LS
.
C
ar
eg
iv
er
s 
of
 p
eo
pl
e 
w
ith
 M
N
D
 
(N
 =
 1
8)
.
M
ea
su
re
 o
n 
fa
m
ily
 c
ar
eg
iv
er
s 
(a
t 
ba
se
lin
e 
an
d 
1 
w
ee
k 
af
te
r 
D
T
):
Z
ar
it 
Bu
rd
en
 In
ve
nt
or
y.
H
H
I.
H
A
D
S.
A
cc
ep
ta
bi
lit
y:
A
 fa
m
ily
 fe
ed
ba
ck
 q
ue
st
io
nn
ai
re
 
(2
0 
ite
m
s)
.
Fe
as
ib
ili
ty
: f
am
ily
 c
ar
eg
iv
er
s’
 
in
vo
lv
em
en
t 
in
 t
he
 t
he
ra
py
, 
tim
e 
ta
ke
n,
 p
ro
to
co
l d
ev
ia
tio
ns
, 
ac
co
m
m
od
at
io
ns
 fo
r 
th
e 
in
te
rv
en
tio
n 
an
d 
re
as
on
s 
fo
r 
no
n-
co
m
pl
et
io
n.
Fa
m
ily
 s
el
f-r
ep
or
ts
 p
re
–p
os
t D
T:
C
ar
eg
iv
er
 b
ur
de
n:
 P
re
: x–
=1
2.
44
, S
D
 =
 7.
89
; P
os
t: 
x– =
16
.2
9,
 S
D
 =
 11
.2
2;
 p
 =
 0.
02
4.
A
nx
ie
ty
: P
re
: x–
=
7.
28
, S
D
 =
 3
.7
1;
 p
os
t: 
x– =
6.
88
, S
D
 =
 4
.3
3;
 p
 =
 0
.2
57
.
D
ep
re
ss
io
n:
 P
re
: x–
=
4.
17
, S
D
 =
 3
.3
3;
 p
os
t: 
x– =
4.
41
, S
D
 =
 3
.9
1;
 p
 =
 0
.8
60
.
H
op
e:
 P
re
: x–
=
38
.3
9,
 S
D
 =
 4
.4
6;
 p
os
t: 
x– =
36
.7
1,
 S
D
 =
 4
.5
2;
 p
 =
 0
.0
83
.
Sa
tis
fa
ct
io
n 
su
rv
ey
:
D
T
 h
el
pf
ul
 t
o 
fa
m
ily
 m
em
be
r:
 x–
=
4.
22
, S
D
 =
 0
.6
4.
D
T
 h
el
pf
ul
 t
o 
fa
m
ily
: x–
=
3.
33
, S
D
 =
 1
.0
8.
D
T
 d
oc
um
en
ts
 a
 s
ou
rc
e 
of
 c
om
fo
rt
 in
 fu
tu
re
: x–
=
3.
83
, S
D
 =
 0
.6
1.
D
T 
w
as
 h
el
pf
ul
 in
 r
ed
uc
in
g 
m
y 
fe
el
in
gs
 o
f s
tr
es
s 
as
 a
 c
ar
er
: x–
=3
.0
0,
 S
D
 =
 0.
90
7.
D
T
 h
el
pe
d 
m
e 
fe
el
 c
lo
se
r 
to
 m
y 
fa
m
ily
 m
em
be
r 
x– =
2.
94
, S
D
 =
 0
.9
38
.
Se
ss
io
ns
 t
o 
co
m
pl
et
e 
D
T
: a
ss
is
te
d 
by
 fa
m
ili
es
 x–
=
3.
75
 v
er
su
s 
4.
41
 a
lo
ne
.
D
ay
s 
to
 c
om
pl
et
e 
in
te
rv
en
tio
n:
 a
ss
is
te
d 
by
 fa
m
ili
es
 x–
=
46
 v
er
su
s 
39
 p
at
ie
nt
 
al
on
e.
T
ab
le
 2
. 
(C
on
tin
ue
d)
Martínez et al. 9
A
ut
ho
r 
(y
ea
r)
, 
co
un
tr
y
M
ai
n 
ob
je
ct
iv
e
T
yp
e 
of
 s
tu
dy
Sa
m
pl
e
D
at
a 
co
lle
ct
io
n
M
ai
n 
re
su
lts
Be
nt
le
y 
et
 a
l.2
7  
(2
01
4)
, A
us
tr
al
ia
T
o 
as
se
ss
 t
he
 fe
as
ib
ili
ty
, 
ac
ce
pt
ab
ili
ty
 a
nd
 p
ot
en
tia
l 
ef
fe
ct
iv
en
es
s 
of
 D
T
 in
 
en
ha
nc
in
g 
en
d-
of
-li
fe
 
ex
pe
ri
en
ce
s 
fo
r 
pe
op
le
 w
ith
 
m
ot
or
 n
eu
ro
n 
di
se
as
e 
(A
LS
).
Pr
e–
po
st
 t
es
t 
de
si
gn
.
In
di
vi
du
al
s 
di
ag
no
se
d 
w
ith
 M
N
D
 
(N
 =
 2
9)
.
H
ea
lth
 s
ta
tu
s:
A
LS
A
Q
-5
.
A
LS
-F
R
S.
M
ea
su
re
s 
at
 b
as
el
in
e 
an
d 
1 
w
ee
k 
af
te
r 
D
T
:
H
H
I.
PD
I.
FA
C
IT
-s
p-
12
.
A
cc
ep
ta
bi
lit
y:
D
T
PF
Q
.
Fe
as
ib
ili
ty
:
T
im
e 
ta
ke
n 
to
 c
on
du
ct
 D
T
, s
pe
ci
al
 
co
nd
iti
on
s.
D
T 
pr
e–
po
st
:
H
op
ef
ul
ne
ss
: p
re
-t
es
t x–
=3
8.
76
, S
D
 =
 5.
10
; p
os
t-
te
st
 x–
=3
6.
61
, S
D
 =
 6.
80
; p
 =
 0.
10
1.
PD
I: 
pr
e-
te
st
 x–
=4
8.
59
, S
D
 =
 1
5.
45
; p
os
t-
te
st
 x–
=4
7.
59
, S
D
 =
 1
2.
91
; p
 =
 0
.5
04
.
Sp
iri
tu
al
ity
: p
re
-t
es
t x–
=3
0.
72
, S
D
 =
 10
.4
3;
 p
os
t-
te
st
 x–
=3
0.
92
, S
D
 =
 9.
88
; p
 =
 0.
93
6.
Sa
tis
fa
ct
io
n 
su
rv
ey
:
92
.8
%
 D
T
 s
at
is
fa
ct
or
y.
89
.2
%
 h
el
pf
ul
 t
o 
th
em
 a
nd
 t
o 
fa
m
ily
 (
85
.2
%
).
84
%
 r
ec
om
m
en
d 
D
T
 t
o 
ot
he
r 
pa
tie
nt
s 
w
ith
 A
LS
.
D
ig
ni
ty
 r
el
at
ed
 t
o 
un
fin
is
he
d 
bu
si
ne
ss
: M
N
D
 x–
=
3.
68
, S
D
 =
 0
.6
1;
 D
T
 
x– =
3.
35
, S
D
 =
 1
.0
1;
 S
PC
 x–
=
2.
86
, S
D
 =
 1
.6
0.
Le
ss
en
ed
 s
ad
ne
ss
 o
 d
ep
re
ss
io
n:
 M
N
D
 x–
=
3.
04
, S
D
 x–
=
3.
11
, S
D
 =
 1
.0
2;
 S
PC
 
x– =
2.
57
, S
D
 =
 0
.9
2.
Le
ss
en
ed
 fe
el
in
g 
of
 b
ur
de
n 
to
 o
th
er
s:
 M
N
D
 x–
=
2.
96
, S
D
 =
 0
.9
2;
 D
T
 x–
=
2.
81
, 
SD
 =
 0
.9
8;
 S
PC
 x–
=
2.
58
, S
D
 =
 0
.9
5.
In
cr
ea
se
d 
w
ill
 t
o 
liv
e:
 M
N
D
 x–
=
2.
96
, S
D
 =
 0
.9
8;
 D
T
 x–
=
2.
94
, S
D
 =
 1
.1
1;
 S
PC
 
x– =
2.
76
, S
D
 =
 1
.0
4.
3–
7 
th
er
ap
y 
se
ss
io
ns
 a
cc
or
di
ng
 t
o 
sp
ec
ifi
c 
ne
ed
s.
D
T
 is
 fe
as
ib
le
 fo
r 
pe
op
le
 w
ith
 A
LS
, b
ut
 it
 is
 n
ec
es
sa
ry
 t
o 
fin
e 
tu
ne
 fo
r 
th
ei
r 
ne
ed
s.
H
ou
m
an
n 
et
 a
l.2
8  
(2
01
4)
, D
en
m
ar
k
St
ud
y 
D
T
 p
ar
tic
ip
at
io
n 
an
d 
an
al
ys
e 
th
e 
re
su
lts
 o
f i
ts
 
ap
pl
ic
at
io
n.
Lo
ng
itu
di
na
l s
tu
dy
.
A
dv
an
ce
d 
ca
nc
er
 p
at
ie
nt
s 
(N
 =
 8
0)
.
M
ea
su
re
m
en
ts
: b
as
el
in
e 
(T
0)
, 
im
m
ed
ia
te
ly
 a
ft
er
 p
er
fo
rm
in
g 
D
T
 
(T
1)
, 2
 w
ee
ks
 la
te
r 
(T
2)
 w
he
n 
th
e 
pa
tie
nt
 h
ad
 o
pp
or
tu
ni
ty
 t
o 
re
ad
 o
r 
sh
ar
e 
do
cu
m
en
t:
SI
SC
 –
 6
 it
em
s.
PD
I.
EO
R
T
C
 Q
LQ
-C
15
 P
A
L.
H
A
D
S.
PP
Sv
2.
D
T
PF
Q
 –
 9
 it
em
s.
D
ep
re
ss
io
n:
 T
0:
 x–
=
5.
9,
 S
D
 =
 3
.9
; T
1:
 d
iff
er
en
ce
 fr
om
 p
re
-m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 0
.6
 (
95
%
 C
I =
 −
4.
4 
to
 1
.5
); 
T2
: d
iff
er
en
ce
 fr
om
 p
re
-
m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 2
 (
95
%
 C
I =
 −
1.
0 
to
 1
.3
).
Pa
tie
nt
s’
 s
en
se
 o
f d
ig
ni
ty
: D
ep
re
ss
io
n:
 T
0:
 x–
=
1.
33
, S
D
 =
 1
.5
5;
 T
1:
 d
iff
er
en
ce
 
fr
om
 p
re
-m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 −
0.
14
 (
95
%
 C
I =
 −
0.
49
 t
o 
0.
21
); 
T2
: 
di
ffe
re
nc
e 
fr
om
 p
re
-m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 −
0.
52
 (
95
%
 C
I =
 −
1.
01
 t
o 
−
0.
02
).
Fe
el
in
g 
of
 b
ei
ng
 a
 b
ur
de
n:
 T
0:
 x–
=
1.
95
, S
D
 =
 1
.0
4;
 T
1:
 d
iff
er
en
ce
 fr
om
 p
re
-
m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 −
0.
02
, (
95
%
 C
I =
 −
0.
29
 t
o 
0.
25
); 
T2
: d
iff
er
en
ce
 
fr
om
 p
re
-m
ea
su
re
m
en
t 
m
ea
n 
sc
or
e 
=
 −
0.
26
 (
95
%
 C
I =
 −
0.
49
 t
o 
−
0.
02
).
Ja
va
lo
ye
s 
et
 a
l.1
0  
(2
01
4)
, S
pa
in
Ev
al
ua
te
 p
re
–p
os
t-
in
te
rv
en
tio
n 
ch
an
ge
s 
in
 D
T
.
Q
ua
si
-e
xp
er
im
en
ta
l 
st
ud
y.
A
dv
an
ce
d 
ca
nc
er
 p
at
ie
nt
s 
(N
 =
 1
6)
.
H
A
D
S.
EV
A
 d
is
co
m
fo
rt
-w
el
l-b
ei
ng
.
T
w
o 
qu
es
tio
ns
 a
bo
ut
 s
at
is
fa
ct
io
n 
an
d 
ut
ili
ty
 u
si
ng
 a
 L
ik
er
t 
sc
al
e.
Pr
e–
po
st
 D
T
:
A
nx
ie
ty
: P
re
: x–
=
8.
56
, S
D
 =
 2
.8
5;
 p
os
t: 
x– =
5.
94
, S
D
 =
 3
.7
1;
 p
 =
 0
.0
10
.
W
el
l-b
ei
ng
: P
re
: x–
=
7.
37
, S
D
 =
 6
.2
7;
 p
os
t: 
x– =
6.
31
, S
D
 =
 6
.0
5;
 p
 =
 0
.0
30
.
D
ep
re
ss
io
n:
 Z
 =
 −
1.
44
, p
 =
 0
.1
49
.
Se
re
ni
ty
: Z
 =
 −
1.
93
, p
 =
 0
.0
53
.
W
id
e 
sa
tis
fa
ct
io
n 
w
ith
 D
T
’s
 c
on
te
nt
 (
x– =
4.
75
) 
an
d 
us
ef
ul
ne
ss
 (
x– =
4.
43
).
Ju
lia
o 
et
 a
l.2
9  
(2
01
4)
, P
or
tu
ga
l
D
et
er
m
in
e 
th
e 
in
flu
en
ce
 
th
at
 D
T
 h
as
 o
n 
de
pr
es
si
on
 
an
d 
an
xi
et
y 
in
 p
at
ie
nt
s 
w
ith
 t
er
m
in
al
 il
ln
es
s 
w
ho
 
ex
pe
ri
en
ce
 h
ig
h 
le
ve
ls
 o
f 
di
st
re
ss
.
R
C
T
.
T
hi
s 
is
 a
 c
on
tin
ua
tio
n 
of
 t
he
 p
ub
lis
he
d 
st
ud
y 
Ju
lia
o 
et
 a
l.2
4  
(2
01
3)
.
Pa
rt
ic
ip
an
ts
 w
ith
 li
fe
-t
hr
ea
te
ni
ng
 
di
se
as
e 
(N
 =
 8
0)
.
In
te
rv
en
tio
n:
 D
T
 +
 S
PC
 (
n 
=
 3
9)
.
C
on
tr
ol
: S
PC
 (
n 
=
 4
1)
.
H
A
D
S 
at
 b
as
el
in
e 
(T
 =
 1
) 
an
d 
on
 d
ay
 
4 
(T
 =
 2
), 
da
y 
15
 (
T 
=
 3
) 
an
d 
da
y 
30
 
(T
 =
 4
) 
af
te
r 
th
e 
th
er
ap
y.
D
ep
re
ss
io
n 
in
te
rv
en
tio
n 
ve
rs
us
 c
on
tr
ol
:
T2
: x–
=
–4
.0
0 
(9
5%
 C
I: 
−
6.
00
 t
o 
−
2.
00
; p
 <
 0
.0
01
).
T3
: x–
=
–4
.0
0 
(9
5%
 C
I =
 −
7.
00
 t
o 
−
1.
00
, p
 =
 0
.0
10
).
T4
: x–
=
–5
.0
0 
(9
5%
 C
I =
 −
8.
00
 t
o 
−
1.
00
, p
 =
 0
.0
43
).
An
xi
et
y 
in
te
rv
en
tio
n 
ve
rs
us
 c
on
tr
ol
:
T2
: x–
=
–3
.0
0 
(9
5%
 C
I =
 5
.0
0 
to
 −
1.
00
, p
 <
 0
.0
01
).
T3
: x–
=
–4
.0
0 
(9
5%
 C
I =
 −
7.
00
 t
o 
−
2.
00
, p
 =
 0
.0
01
).
T4
: x–
=
–4
.0
0 
(9
5%
 C
I =
 −
7.
00
 t
o 
−
1.
00
, p
 =
 0
.0
13
).
T
ab
le
 2
. 
(C
on
tin
ue
d)
 (C
on
tin
ue
d)
10 Palliative Medicine 
A
ut
ho
r 
(y
ea
r)
, 
co
un
tr
y
M
ai
n 
ob
je
ct
iv
e
T
yp
e 
of
 s
tu
dy
Sa
m
pl
e
D
at
a 
co
lle
ct
io
n
M
ai
n 
re
su
lts
V
er
go
 e
t 
al
.30
 
(2
01
4)
, U
SA
A
ss
es
s 
th
e 
fe
as
ib
ili
ty
 o
f D
T
 
re
la
tiv
el
y 
ea
rl
y 
in
 t
he
 d
is
ea
se
 
tr
aj
ec
to
ry
 a
nd
 t
he
 e
ffe
ct
 o
n 
ac
ce
pt
in
g 
de
at
h,
 d
is
tr
es
s,
 
sy
m
pt
om
s,
 q
ua
lit
y 
of
 li
fe
, 
pe
ac
ef
ul
ne
ss
 a
nd
 a
dv
an
ce
d 
ca
re
 p
la
nn
in
g.
C
ro
ss
-s
ec
tio
na
l o
ne
 
gr
ou
p 
pr
e–
po
st
 t
es
t 
de
si
gn
.
Pa
tie
nt
s 
w
ith
 s
ta
ge
-IV
 c
ol
or
ec
ta
l 
ca
nc
er
 r
ec
ei
vi
ng
 p
al
lia
tiv
e 
ch
em
ot
he
ra
py
 (
N
 =
 1
5)
.
Li
ke
rt
.
T
IA
.
ES
A
S.
D
is
tr
es
s 
th
er
m
om
et
er
.
2-
ite
m
 Q
oL
 S
ca
le
.
H
-C
A
P-
S.
D
T
PF
Q
-5
 it
em
s.
Sa
tis
fa
ct
io
n 
su
rv
ey
:
10
0%
 s
at
is
fie
d 
w
ith
 D
T
.
88
%
 D
T
 h
el
pf
ul
.
88
%
 in
cr
ea
se
d 
th
ei
r 
se
ns
e 
of
 m
ea
ni
ng
.
78
%
in
cr
ea
se
d 
th
ei
r 
se
ns
e 
of
 m
ea
ni
ng
.
88
%
 t
ho
ug
ht
 it
 w
as
 h
el
pf
ul
 t
o 
th
ei
r 
fa
m
ily
.
78
%
 D
T
 in
cr
ea
se
d 
se
ns
e 
of
 d
ig
ni
ty
 a
nd
 p
ur
po
se
.
67
%
 D
T
 in
cr
ea
se
d 
th
ei
r 
w
ill
 t
o 
liv
e.
N
o 
ch
an
ge
s 
in
 p
hy
si
ca
l a
nd
 e
m
ot
io
na
l s
ym
pt
om
s 
(n
 =
 9
).
A
ou
n 
et
 a
l.3
1  
(2
01
5)
, A
us
tr
al
ia
T
o 
as
se
ss
 t
he
 a
cc
ep
ta
bi
lit
y,
 
fe
as
ib
ili
ty
 a
nd
 e
ffe
ct
iv
en
es
s 
of
 
D
T
 fo
r 
re
du
ci
ng
 d
is
tr
es
s 
in
 
pe
op
le
 w
ith
 M
N
D
 a
nd
 t
he
ir
 
fa
m
ily
 c
ar
eg
iv
er
s.
Pr
e-
 a
nd
 p
os
t-
in
te
rv
en
tio
n 
de
si
gn
.
n 
=
 2
7 
pa
tie
nt
s 
an
d 
n 
=
 1
8 
ca
re
gi
ve
rs
.
Pa
rt
ic
ip
an
ts
 r
ec
ru
ite
d 
fr
om
 t
he
 
M
N
D
 A
ss
oc
ia
tio
n 
of
 W
es
te
rn
 
A
us
tr
al
ia
.
35
 c
lie
nt
s,
 2
7 
pa
tie
nt
s 
co
m
pl
et
ed
 
th
e 
st
ud
y;
 1
8 
fa
m
ily
 m
em
be
r 
ca
re
gi
ve
rs
 p
ar
tic
ip
at
ed
.
Po
st
-t
es
tin
g 
1 
w
ee
k 
af
te
r 
D
T
 
th
ro
ug
h 
qu
es
tio
nn
ai
re
.
Fe
as
ib
ili
ty
: n
um
be
r 
of
 v
is
its
 b
y 
th
er
ap
is
t, 
nu
m
be
r 
of
 d
ay
s 
to
 
co
m
pl
et
e 
th
e 
th
er
ap
y,
 t
im
e 
ta
ke
n 
by
 t
he
ra
pi
st
 t
o 
de
liv
er
 t
he
 t
he
ra
py
.
A
cc
ep
ta
bi
lit
y:
 P
ar
tic
ip
an
ts
’ v
ie
w
s 
on
 
w
he
th
er
 D
T
 h
el
pe
d 
th
em
 o
r 
th
ei
r 
fa
m
ili
es
.
Pa
tie
nt
 fe
ed
ba
ck
: Q
O
L,
 s
pi
ri
tu
al
 
w
el
l-b
ei
ng
, s
en
se
 o
f c
on
tr
ol
 o
f 
on
e’
s 
ow
n 
lif
e,
 fe
el
in
g 
m
or
e 
re
sp
ec
te
d 
an
d 
un
de
rs
to
od
.
C
ar
eg
iv
er
 fe
ed
ba
ck
:
Ef
fe
ct
iv
en
es
s 
ou
tc
om
es
:
PD
I.
A
LS
A
Q
-5
.
FA
C
IT
-s
p-
12
.
H
H
I.
Z
BI
-1
2.
H
A
D
S.
Pa
tie
nt
s:
PD
I: 
Pr
e:
 x–
=
 4
9.
82
, S
D
 =
 1
5.
72
; p
os
t: 
x– =
 4
9.
14
, S
D
 =
 1
2.
83
; p
 =
 0
.6
7.
H
op
e:
 P
re
: x–
=
 3
8.
60
, S
D
 =
 5
.1
3;
 p
os
t: 
x– =
 3
6.
76
, S
D
 =
 6
.5
4;
 p
 =
 0
.2
0.
Sp
ir
itu
al
 w
el
l-b
ei
ng
: P
re
: x–
=3
0.
76
, S
D
 =
 1
0.
08
; p
os
t: 
 x–
= 
31
.0
4,
 S
D
 =
 9
.6
2;
 
p 
= 
0.
82
.
Q
oL
: P
re
: x–
=
 9
.4
4,
 S
D
 =
 3
.8
9;
 p
os
t: 
x– =
 9
.2
8,
 S
D
 =
 3
.7
7;
 p
 =
 0
.7
3.
Fa
m
ily
 m
em
be
r 
ca
re
gi
ve
rs
:
C
ar
eg
iv
er
 b
ur
de
n:
 P
re
: x–
=
12
.7
6,
 S
D
 =
 8
.0
1;
 p
os
t: 
x– =
16
.2
9,
 S
D
 =
 1
1.
22
; 
p 
=
 0
.0
55
.
H
op
e:
 P
re
: x–
=
 3
8.
35
, S
D
 =
 4
.5
9;
 p
os
t: 
x– =
 3
6.
71
, S
D
 =
 4
.5
2;
 p
 =
 0
.1
0.
A
nx
ie
ty
: P
re
: x–
=
 7
.5
3,
 S
D
 =
 3
.6
5;
 p
os
t: 
x– =
 6
.8
8,
 S
D
 =
 4
.3
2;
 p
 =
 0
.2
5.
D
ep
re
ss
io
n:
 P
re
: x–
=
 4
.3
5,
 S
D
 =
 3
.3
3;
 p
os
t: 
x– =
 4
.4
1,
 S
D
 =
 3
.9
0;
 p
 =
 0
.9
0.
89
%
 D
T
 h
el
pf
ul
 fo
r 
m
e 
(p
at
ie
nt
) 
an
d 
81
%
 u
se
fu
l f
or
 m
y 
fa
m
ily
.
Jo
hn
st
on
 e
t 
al
.32
 
(2
01
6)
, U
K
A
ss
es
s 
fe
as
ib
ili
ty
, 
ac
ce
pt
ab
ili
ty
 a
nd
 p
ot
en
tia
l 
ef
fe
ct
iv
en
es
s 
of
 D
T
.
M
ix
ed
-m
et
ho
d 
st
ud
y.
27
 p
ar
tic
ip
an
ts
.
7 
pa
tie
nt
s 
w
ith
 e
ar
ly
-s
ta
te
 
de
m
en
tia
 (
ES
D
), 
7 
fa
m
ily
 
m
em
be
rs
, 7
 s
ta
ke
ho
ld
er
 a
nd
 6
 
fo
cu
s 
gr
ou
p 
m
em
be
rs
.
D
T
 s
um
m
ar
ie
s.
Po
st
-D
T
 in
te
rv
ie
w
s.
Fo
cu
s 
gr
ou
p 
da
ta
.
St
ak
eh
ol
de
rs
 in
te
rv
ie
w
.
O
ut
co
m
es
 m
ea
su
re
s:
 H
H
I, 
PD
I, 
Q
oL
.
Pa
tie
nt
s 
ha
d 
no
 p
ro
bl
em
s 
to
 c
om
pl
et
e 
th
e 
th
er
ap
y 
on
 t
he
ir
 o
w
n.
Pa
tie
nt
s 
ve
ry
 o
pe
n 
ab
ou
t 
em
ot
io
ns
, r
ea
ct
io
ns
 a
nd
 fa
m
ily
 s
itu
at
io
n.
 T
he
y 
tr
us
te
d 
an
d 
fe
lt 
co
m
fo
rt
ab
le
 s
ha
ri
ng
 t
he
ir
 li
fe
 e
xp
er
ie
nc
es
.
A
ll 
pa
rt
ic
ip
an
ts
 fo
un
d 
D
T
 b
en
ef
ic
ia
l a
nd
 D
T
 d
oc
um
en
t 
ac
cu
ra
te
.
O
ve
ra
rc
hi
ng
 t
he
m
es
 fo
r 
D
T
: a
 li
fe
 in
 c
on
te
xt
, a
 k
ey
 t
o 
co
nn
ec
t, 
pe
rs
on
al
 
le
ga
cy
. P
ar
tic
ip
an
ts
 fe
lt 
th
at
 D
T
 w
ou
ld
 b
e 
of
 b
en
ef
it 
in
 fu
tu
re
 y
ea
rs
, h
el
pi
ng
 
fa
m
ily
 o
r 
ca
re
rs
 t
o 
co
nn
ec
t 
be
tt
er
 w
ith
 t
he
 p
er
so
n 
an
d 
ac
t 
as
 a
 r
em
in
de
r.
Fa
m
ili
es
 in
te
re
st
ed
 in
 e
ar
lie
r 
pa
rt
s 
of
 p
at
ie
nt
s’
 li
ve
s 
th
at
 t
he
y 
w
er
e 
pr
ev
io
us
ly
 u
na
w
ar
e 
of
.
Pe
rc
ei
ve
d 
pr
ob
le
m
s 
re
la
tin
g 
to
 is
su
es
 t
ha
t 
m
ig
ht
 a
ffe
ct
 d
ig
ni
ty
 w
er
e 
ge
ne
ra
lly
 lo
w
.
T
ab
le
 2
. 
(C
on
tin
ue
d)
Martínez et al. 11
A
ut
ho
r 
(y
ea
r)
, 
co
un
tr
y
M
ai
n 
ob
je
ct
iv
e
T
yp
e 
of
 s
tu
dy
Sa
m
pl
e
D
at
a 
co
lle
ct
io
n
M
ai
n 
re
su
lts
Li
nd
qv
is
t 
et
 a
l.3
4  
(2
01
5)
, S
w
ed
en
A
na
ly
se
 t
he
 e
xp
er
ie
nc
e 
of
 
pa
rt
ic
ip
at
in
g 
in
 D
T
.
Q
ua
lit
at
iv
e 
st
ud
y.
8 
pa
tie
nt
s.
In
te
rv
ie
w
.
( 
x– =
14
 s
ur
vi
va
l d
ay
s 
af
te
r 
D
T
).
St
af
f c
on
si
de
re
d 
D
T
 u
ns
ui
ta
bl
e 
fo
r 
52
/6
2 
pa
tie
nt
s 
du
e 
to
 r
ap
id
 
de
ge
ne
ra
tio
n,
 fr
ai
lty
 o
r 
co
gn
iti
ve
 im
pa
ir
m
en
t.
So
m
e 
ca
nd
id
at
es
 c
on
si
de
re
d 
D
T
: s
up
er
flu
ou
s 
to
 im
m
ed
ia
te
 n
ee
ds
, 
ph
ys
ic
al
ly
 a
nd
 e
m
ot
io
na
lly
 u
nb
ea
ra
bl
e,
 D
T
 q
ue
st
io
ns
 t
oo
 p
re
te
nt
io
us
 fo
r 
th
em
.
T
he
ra
pi
st
 r
ef
le
ct
io
n:
 s
he
 m
ay
 in
ad
ve
rt
en
tly
 s
te
er
ed
 p
at
ie
nt
 a
w
ay
 fr
om
 h
er
 
ow
n 
ob
je
ct
iv
es
 in
 fo
rm
in
g 
he
r 
le
ga
cy
.
Li
tt
le
 a
dh
er
en
ce
 t
o 
th
er
ap
y 
an
d 
di
ffi
cu
lti
es
 in
 it
s 
im
pl
em
en
ta
tio
n 
du
e 
to
 
th
e 
cu
ltu
ra
l c
on
te
xt
.
Ju
lia
o 
et
 a
l.3
3  
(2
01
5)
, P
or
tu
ga
l
D
et
er
m
in
e 
w
he
th
er
 D
T
 
of
fe
rs
 a
 s
ur
vi
va
l a
dv
an
ta
ge
 
to
 s
ta
nd
ar
d 
pa
lli
at
iv
e 
ca
re
 
(S
PC
).
R
C
T
.
T
hi
s 
is
 a
 p
ar
t 
of
 t
he
 
pu
bl
is
he
d 
st
ud
y 
Ju
lia
o 
et
 a
l.2
9  
(2
01
4)
.
80
 p
ar
tic
ip
an
ts
.
D
T
 +
 S
PC
 in
te
rv
en
tio
n 
n 
=
 3
9;
 
SP
C
 c
on
tr
ol
 n
 =
 4
1.
Pr
e-
in
te
rv
en
tio
n:
H
A
D
S.
PP
S.
M
M
SE
.
Po
st
-in
te
rv
en
tio
n:
 S
ur
vi
va
l t
im
e.
Su
rv
iv
al
 fo
r 
D
T
: 2
6.
1 
da
ys
 (
95
%
 C
I: 
23
.2
–2
0.
0)
.
Su
rv
iv
al
 c
on
tr
ol
 g
ro
up
: 2
0.
8 
da
ys
 (
95
%
 C
I: 
17
.4
–2
4.
2)
; s
ur
vi
va
l h
az
ar
d 
ra
tio
 
fo
r 
D
T
 g
ro
up
: 0
.3
5 
(9
5%
 C
I =
 0
.1
3–
09
2)
.
R
ud
ill
a 
et
 a
l.1
1  
(2
01
6)
, S
pa
in
A
na
ly
se
 t
he
 e
ffe
ct
s 
of
 D
T
 
an
d 
co
un
se
lli
ng
 in
 h
om
e 
ca
re
 
pa
tie
nt
s.
Pi
lo
t 
R
C
T
.
Pa
lli
at
iv
e 
ho
m
e 
ca
re
 p
at
ie
nt
s 
(N
 =
 7
0)
.
Pr
e–
po
st
 in
te
rv
en
tio
n:
PD
I.
H
A
D
S.
BR
C
S.
G
ES
 Q
ue
st
io
nn
ai
re
.
D
uk
e-
U
N
C
-1
1 
Fu
nc
tio
na
l S
oc
ia
l 
Su
pp
or
t 
Q
ue
st
io
nn
ai
re
.
EO
R
T
C
-Q
LQ
-C
30
 (
2 
ite
m
s)
.
Pe
ac
e 
of
 m
in
d:
 P
re
-D
T
: x–
=
 2
.5
2,
 S
D
 =
 0
.7
5;
 p
os
t-
D
T
: x–
=
1.
76
, S
D
 =
 0
.5
8,
 
p 
<
 0
.0
01
.
Q
oL
: P
re
-D
T
:  
x– =
 3
.3
1,
 S
D
 =
 1
.5
0;
 p
os
t-
D
T
: x–
=
 4
.0
7,
 S
D
 =
 2
1.
17
, p
 =
 0
.0
11
.
D
ep
re
ss
io
n:
 P
re
-D
T
: x–
=
11
.5
4,
 S
D
 =
 2
.4
0;
 p
os
t-
D
T
: x–
=
13
.1
1,
 S
D
 =
 1
.7
7,
 
p 
=
 0
.0
01
.
D
T
: d
ig
ni
ty
 t
he
ra
py
; R
C
T
: r
an
do
m
iz
ed
 c
on
tr
ol
le
d 
tr
ia
l (
m
et
ho
do
lo
gy
); 
A
LS
A
Q
-5
: A
m
yo
tr
op
hi
c 
La
te
ra
l S
cl
er
os
is
 A
ss
es
sm
en
t 
Q
ue
st
io
nn
ai
re
-5
; A
LS
-F
R
S-
R
5:
 A
m
yo
tr
op
hi
c 
La
te
ra
l S
cl
er
os
is
 F
un
ct
io
na
l R
at
in
g 
Sc
al
e–
R
ev
is
ed
-5
; B
R
C
S:
 
Br
ie
f R
es
ili
en
t 
C
op
in
g 
Sc
al
e;
 D
uk
e-
U
N
C
-1
1:
 F
un
ct
io
na
l S
oc
ia
l S
up
po
rt
 Q
ue
st
io
nn
ai
re
; E
O
R
T
C
-Q
LQ
-C
30
: E
O
R
T
C
 Q
ua
lit
y 
of
 L
ife
 C
30
 Q
ue
st
io
nn
ai
re
; D
T
PF
Q
: D
ig
ni
ty
 T
he
ra
py
 P
at
ie
nt
 F
ee
db
ac
k 
Q
ue
st
io
nn
ai
re
; E
V
A
: V
is
ua
l A
na
lo
g 
Sc
al
e;
 E
SA
S:
 E
dm
on
to
n 
Sy
st
em
 A
ss
es
sm
en
t 
Sc
al
e;
 F
A
C
IT
-P
A
L:
 F
un
ct
io
na
l A
ss
es
sm
en
t 
of
 C
hr
on
ic
 Il
ln
es
s 
T
he
ra
py
–P
al
lia
tiv
e 
C
ar
e;
 G
D
S:
 G
er
ia
tr
ic
 D
ep
re
ss
io
n 
Sc
al
e;
 G
ES
: G
en
er
al
 E
m
er
ge
nc
y 
Se
rv
ic
es
 (
G
ES
 q
ue
st
io
nn
ai
re
 o
f s
pi
ri
tu
al
-
ity
); 
H
A
D
S:
 H
os
pi
ta
l A
nx
ie
ty
 a
nd
 D
ep
re
ss
io
n 
Sc
al
e;
 H
-C
A
P-
S:
 H
yp
ot
he
tic
al
 A
dv
an
ce
d 
C
ar
e 
Pl
an
ni
ng
 S
ce
na
ri
o;
 H
H
I: 
H
er
th
 H
op
e 
In
de
x;
 M
M
SE
: M
in
i-M
en
ta
l S
ta
te
 E
xa
m
in
at
io
n;
 P
D
I: 
Pa
tie
nt
 D
ig
ni
ty
 In
ve
nt
or
y;
 P
PS
v2
: P
al
lia
tiv
e 
Pe
rf
or
-
m
an
ce
 S
ca
le
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questionnaire for measuring health-related quality of life 
and satisfaction with quality of life. No significant differ-
ences were identified on the PDI between groups at any 
time point; observing in the control group an improvement 
in dignity-related stress along the follow-up compared 
with baseline data. In the intervention group, there was a 
slight improvement in the first week which was not main-
tained at fourth week16 (Table 2). Regarding hope, the con-
trol group observed a decrease during the follow-up, and 
the intervention group observed an improvement at weeks 
1 and 4, compared with baseline data.16
A randomized clinical trial was conducted with 60 
elderly patients in nursing homes.19 The intervention 
group was treated with DT (n = 31) and the control 
group with standard psychosocial care group (n = 29).  
The following measures were assessed in both groups 
at the baseline and at weeks 1 and 8: PDI, Geriatric 
Depression Scale (Short Form), HHI and Quality-of-Life 
Questionnaire. Baseline data measured by the PDI showed 
low distress levels related to dignity; hopefulness and 
quality-of-life levels were high. In both groups, PDI score 
increased after 1 week and decreased at week 8 and hope-
fulness and quality-of-life levels were high. No signifi-
cant differences between the intervention and control 
groups were found on the evaluation timeline19 (Table 2).
In Portugal, 80 terminal patients were randomized to an 
intervention group receiving DT plus standard PC (n = 39) 
and into a control group receiving only standard palliative 
care (SPC) (n = 41).29 The HADS showed that patients had 
a high level of distress at baseline (T1; HADS depres-
sion > 11 in both groups), and it was measured also 4, 15 
and 30 days after the end of DT (T2, T3 and T4, respec-
tively). The preliminary results with 60 patients (DT, 
n = 29; PC, n = 31)24 found decrease in depressive symp-
toms in the DT group after 4 days compared with baseline 
data and 15 days, but not at 30 days (Table 2). They also 
found a significant decrease in anxiety according to the 
various measures.24 In a later publication with the results 
of 80 patients (DT, n = 39; SPC, n = 41), while the DT 
group always showed better scores than at baseline for 
both depression and anxiety, the control group always 
showed worse scores than at baseline. The differences at 
follow-up (4, 15 and 30 days) between DT and control 
groups were statistically significant29 (Table 2). In a sec-
ondary analysis, they studied whether DT offered a signifi-
cantly higher survival compared to SPC. The survival time 
for DT group was higher (26.1 vs 20.8 days)33 (Table 2).
The most recent pilot randomized controlled trial (RCT) 
was carried out in Spain at a home care unit with 64 
patients assigned to two therapy groups: DT (n = 32) and 
counselling (C) (n = 32), although limited information is 
provided regarding how the therapies were conducted.11 
The measurement instruments employed were PDI, 
HADS, Brief Resilient Coping Scale (BRCS), GES 
Questionnaire of spirituality, Duke-UNC-11 Functional 
Social Support Questionnaire and 2 items of the EORTC-
QLQ-C30 of quality of life. They report statistically sig-
nificant differences with respect to the dimensions of 
dignity, anxiety, spirituality and QoL comparing pre–post 
data within DT group. The data provided for counselling 
group compare the post-counselling with DT group’s base-
line data so the comparison is not meaningful. Depression 
increased significantly in the DT group after the interven-
tion, and there were no differences with respect to resil-
ience. They also calculated the differences between groups 
post intervention and found statistically significant differ-
ences in anxiety, with lower scores in the counselling 
group DT versus counselling (Table 2). However, there is 
no comparison about the magnitude of the effect among 
the interventions.
Nonrandomized studies. In Canada, a non-randomized 
study was conducted to evaluate DT’s impact on psycho-
social and existential distress (n = 100).13 Distress was 
assessed using the Structured Interview for Symptoms and 
Concerns (SISC) – a tool measuring depression, dignity, 
anxiety, pain, hope, desire to die, suicide and well-being. 
This also included the ESAS and 2 items to measure qual-
ity of life and a scale measuring will to live. They evalu-
ated these pre- and post-DT aspects. In addition, a 
satisfaction questionnaire was used to assess participants’ 
perception of DT.
The suffering measure showed significant improve-
ment post intervention, as well as self-reported depression 
(Table 2). No significant changes were found in scores of 
despair, wanting to die, anxiety and suicide. They found 
that family support correlated positively and moderately 
with meaning in life and sense of direction and weakly 
with sense of suffering and will to live. Patients who 
reported greater initial psychosocial distress benefited 
from therapy, which was reflected in weak correlations 
with quality of life, satisfaction of quality of life and desire 
for death13 (Table 2).
Two pre- and post studies have evaluated DT’s effec-
tiveness with patients suffering from Amyotrophic Lateral 
Sclerosis (ALS).27,31 The first one was conducted with 29 
patients assessing the following aspects at baseline and 
1 week after completing the DT: HHI, FACIT-sp, PDI, 
ALS Assessment Questionnaire and ALS Cognitive 
Behavioural Screen. They were also sent a 25-item ques-
tionnaire to explore DT’s suitability, adding three items 
about hope and social support (5-point Likert scale). At 
baseline, the group was hopeful, but experienced low-dig-
nity-related distress and seemed to feel that their spiritual 
well-being was low. No significant changes in hope, dig-
nity and spirituality between the pre- and post-intervention 
assessments were found27 (Table 2), but participants and 
families considered DT was very helpful.
The second study was conducted with motor neuron 
disease (MND) patients (n = 27) and their families 
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(n = 18).31 The PDI, QoL, FACIT-sp, HHI, HADS for fam-
ily members and Zarit for the caregiver were administrated 
pre–post DT (1 week after handing the DT document). In 
this study, no significant changes were found before and 
after DT on measures of dignity-related distress, or in 
quality of life, spiritual well-being or hope (Table 2). No 
differences in measures related to caregiver burden, anxi-
ety depression or hope were found,31 but participants 
reported DT was helpful for them and their families, as in 
other studies.27
A quasi-experimental study with data on the impact of 
DT on advanced cancer patients was carried out in Spain 
(n = 16). Patients’ discomfort and suffering were assessed 
by HADS and visual analogic scales of well-being and suf-
fering at the baseline and 1 week after, as well as some 
questions about satisfaction and usefulness. The results 
show a statistically significant difference in the anxiety 
and well-being. However, there was no statistically signifi-
cant difference for depression and serenity10 (Table 2).
Satisfaction, suitability and feasibility of DT
Patients’ general satisfaction with DT. In 2005, Chochinov 
et al.13 carried out a DT satisfaction survey, assessed with 
a 0- to 7-point ordinal scale, in 100 hospice patients. Most 
of the patients were satisfied (⩾4 points; 91%) with DT. 
The majority considered it useful or very useful and help-
ful for them and their families. More than half said it 
increased their sense of dignity, hope, and their sense of 
purpose. In all, 47% of participants indicated that DT 
increased their desire to live13 (Table 2).
Later Chochinov study results are along the same lines. 
Patients participating in the first (RCT on DT (n = 441) 
showed improvements in perception on various dimen-
sions of end-of-life experience.15 The DT group found the 
intervention more helpful and had improved perceptions 
on quality of life, sense of dignity and perceptions of sad-
ness or depression improved. Perceived improvements 
concerning quality of life and sense of dignity were greater 
and statistically significant in the DT group. In addition, 
patients reported that it also changed how their families 
saw and appreciated them and that it was useful for the 
family. Patients perceived DT was also significantly better 
than PC at reducing sadness or depression15 (Table 2).
In another RCT on DT,16 patients in the intervention group 
were more positive than the control group on all the scores 
related to self-perceived benefits after 4 weeks: help received, 
greater sense of purpose, although greater meaning in life, 
and family support were not statistically significant (Table 2).
Subsequent studies have further examined participants’ 
satisfaction using more qualitative approaches. In one case 
study,21 three PC patients with high levels of dignity-
related distress were chosen as cases. The patients believed 
that DT was useful for them and would be so for their fam-
ilies. Levels of dignity-related distress increased in two 
patients 4 weeks after the therapy, but not in the third; but 
scores always remained lower than at baseline (Table 2); 
as it remained below the baseline level, the patients contin-
ued to believe that DT had been worthwhile. Along those 
lines, the three patients reported aspects such as DT help-
ing to become aware that his life has not always been a life 
of illness and disability, allowing to accept limitations and 
providing opportunities to explore feelings and fears and 
reveal suffering to family members (Table 2).
Another study,22 which compares elderly participants’ 
perceptions in a DT (n = 25) and control group (n = 24), 
revealed differences and similarities (Table 2). Some par-
ticipants considered the legacy document useful and it 
made them feel important, while other comments were 
quite neutral. Others felt that the legacy document opened 
up their family history, reviewing positive aspects of their 
lives and sharing their stories and would help to be remem-
bered after they died. Participants appreciated their inter-
action with the therapist as a positive change in their daily 
routine after the DT. Neither group thought that it had 
helped them with their problems related to coping with 
loss and distress symptoms22 (Table 2).
In a similar study with cancer patients who were being 
treated with PC, similarities and differences between the 
control (n = 23) and DT (n = 22) groups were also found.23 
The legacy document was identified as an opportunity to 
feel that their life was worthwhile and say things that they 
could not say in person. In both groups, patients reported 
feeling more positive and motivated to do things. They 
also mentioned the interviewer and therapist’s abilities in 
that they made them feel good. In addition, in both groups, 
but more so in the DT group, they noted that they had 
reviewed their life and improved communication with 
their families and that it had influenced their personal rela-
tionships23 (Table 2).
Regarding possible distress caused by the therapy or 
research, many participants described positive experiences 
regarding their participation. Nobody mentioned being 
particularly distressed, but some showed a bit of concern 
with the content of their legacy document and the recipi-
ents’ possible reactions to it.23 The presence of these con-
cerns raises the question of how DT was applied, as the 
protocol includes helping directly patients so that they 
shape their document in a way that will not cause them 
distress or problems or inflict harm to recipients of the 
document. In a small sample of terminally ill patients 
(n = 4), compared to baseline, post-intervention mean 
depression and anxiety scores increased (Table 2). 
However, the majority of patients believed that the therapy 
had been helpful to them and their families.9 Another study 
confirms patient’s positive perception of DT in patients 
with colorectal cancer.30 More than two-thirds of the par-
ticipants (n = 15) reported that DT was helpful and 
increased their sense of meaning, sense of dignity and pur-
pose and their will to live30 (Table 2).
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Families’ general satisfaction with DT. One study asked fam-
ily members retrospectively (n = 60) about their percep-
tions of DT’s impact.7 The vast majority considered that it 
had helped the patient. More than two-thirds believed that 
the patient’s perception of dignity and meaning in life had 
increased and more than half that the therapy had helped 
the patient in preparing for death and emphasized the 
importance of implementing this therapy as part of care 
(Table 2). In all, 43% said DT reduced their loved one’s 
suffering.7 Similarly, in a recent study, 89% of families 
said the therapy was helpful for patients with ALS.31
A qualitative study carried out in Canada in 24 relatives 
pointed that DT was believed helpful to their loved ones, 
and more than half felt that it was an important component 
of their loved ones’ care18 (Table 2). They also stated that 
DT gave them the opportunity to discuss their feelings and 
reflect on their lives.18 In another study, the families of the 
elderly saw DT positively and they mentioned that the 
interaction with the therapist was valuable for their elderly 
family member by providing them company and helping 
them assesses their life positively. In addition, family 
members highlighted that DT offers the opportunity to 
communicate and get to know new parts of their lives.20
As for the therapy’s influence on the family, no signifi-
cant results in terms of burnout syndrome, anxiety, depres-
sion or an increase in hope are available in the two 
identified studies measuring DT’s impact on the family 
using pre–post measurements26,31 (Table 2). However, rel-
atives of ALS patients appreciated DT and felt that it 
would help them during the grieving period26 (Table 2).
The studies coincide in showing that family members 
feel that DT helps them7,9,20 (Table 2). In several studies, 
about 70% of families mentioned that the legacy document 
will be of great help to them both at present and in the 
future.7,26,31 At the same time, some relatives wonder about 
the possible negative impact of the legacy document,7,20 
depending on the family’s level of acceptance regarding 
the patient’s death or on the present relationship between 
the patient and his/her relatives.26 This underscores why 
therapists must be skilled in helping patients navigate 
through DT, hence mitigating possible negative conse-
quences of generativity documents on recipients.
Families recommend DT to other patients and their 
families in the same situation, ranging from 70%31 to 
95%.7 Other study shows how the 33.3% of families noted 
that their stress was reduced and hopes raised, 50% 
reported that it was useful in facing death, and 72% agreed 
that DT is and will remain a source of comfort for them.7,31
Professionals’ satisfaction regarding DT. Health professionals’ 
perceptions regarding DT have been assessed in some arti-
cles, including the views of physicians, nurses, social 
workers, psychiatrics and chaplains.
In a qualitative study with 18 PC professionals, they 
considered DT worthwhile because it reduced the patient’s 
pain and suffering.25 In addition, the majority of profes-
sionals felt that it would be helpful for the patient’s family 
in the future and suggested therapy to patients because 
they thought that it helped them to reflect on their lives and 
share stories and lessons (Table 2). In all, 50% of profes-
sionals believed DT reaffirmed patients’ beliefs and values 
and gave them meaning in life; they also thought it would 
help their suffering related to dignity and prepare them for 
the future.25 Regarding the influence that the therapy had 
on professionals, they were able to get to know patients 
who allowed them to read their legacy documents better 
and to be more in tune with them, increasing their job sat-
isfaction.25 Professionals held that DT had a positive effect 
on how they provided care and how they assessed the 
patient and had helped them to better understand the 
patient18 (Table 2).
Suitability of DT. Studies report high participating rates 
(>80%)13,17 and low dropout rate (22%).13 Only a Japa-
nese study reports low participating rates (14%).8 In 
fact, those who refused to participate were concerned 
that it would make them think about death and won-
dered why it was offered to them while they were 
dying.8 This raise questions about how DT was pre-
sented, as DT has been done with non-terminal popula-
tions and in those context is presented as an opportunity 
for reminiscence and personal reflection. DT must 
always be offered in a way that respects the patient’s 
healthy defences and is mindful of their degree of 
acceptance regarding their prognosis8 (Table 2).
Several studies have analysed the suitability of DT by 
measuring whether participants consider it useful or 
helpful.16,19,26,27,31 One study showed that cancer patients 
who received DT perceived that they were more sup-
ported than those receiving standard care, as well as had 
more purpose in their lives16 (Table 2). In a qualitative 
study in patients with ALS (n = 29), the vast majority of 
them considered the DT satisfactory or helpful. They 
reported greater benefits in the areas of dignity related to 
unfinished business, but less in feeling like a burden, 
increase in will to live and decrease in sadness or depres-
sion. The majority considered it useful for their family 
and would recommend it to other ALS patients27 (Table 
2). ALS patients’ relatives identified positive impacts of 
DT on the patient regarding themselves, and more rela-
tives transmitted that DT was helpful to them (n = 9), but 
some did not (n = 4). Relatives reported greater benefits 
in the areas of DT legacy as a source of comfort for them, 
but less in reducing their feelings of stress as a carer or 
helping feel closer to their partner.26
A Swedish study analyses the suitability of DT consid-
ering data and reflections from professionals involved in 
its development with eight patients.34 Professionals believe 
that many patients are not suited for DT because their 
health deteriorates so rapidly and because of frailty or 
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cognitive impairment. Professionals also pondered the 
lack of clarity on what kind of patient could most benefit 
from therapy. In addition, some patients (n = 11) refused 
therapy because they considered it largely ineffective for 
immediate needs or because they saw it as difficult to 
physically or emotionally sustain. The retrospective analy-
sis of the data suggests that they may have overzealously 
followed the DT question framework and at times inad-
vertently steered away the patient from her own objectives 
in forming her legacy,34 which raise questions about thera-
pist’s preparation to conduct DT.
Feasibility of DT. Some studies consider the influence that 
the patient’s cognitive or physical condition has during 
the course of therapy on DT feasibility. In a Canadian 
study with elderly patients, the results regarding DT were 
positive,18 more than half of patients accepting to partici-
pate. In other study, it was expected to systematically 
recruit patients to DT among those enrolled in the spe-
cialized palliative home care service, but this resulted 
less feasible than expected. Staff deemed DT unsuitable 
for 52 of 62 patients due to patients’ deterioration, frailty 
and cognitive impairment. Besides, 11 of the 19 patients 
who were directly approached choose not to participate.34 
In a study conducted with patients with early-state 
dementia, participants did not have difficulties to recol-
lect minute details from the past although it is mentioned 
the need for the time between meetings to be fairly short 
to help with memory.32
In addition, a study of ALS patients living with their 
families in metropolitan and rural areas in Australia lists 
aspects that need to be considered when calculating the 
costs necessary for the completion of this therapy (medical 
training, interviews, document editing and getting to and 
from appointments). Considering these aspects on their 
experience, they say that therapy is unfeasible in small 
organizations with limited resources, although still feasi-
ble in larger places.31
Another study of patients treated with PC services pro-
vides the economic cost of DT and argues that the cost is 
reasonable and profitable for the organization17 (Table 2). 
Thus, a majority of healthcare professionals believed that 
despite the added cost, the expense was worthwhile.25 
Finally, there was a study on DT’s feasibility via telemedi-
cine. In the study, they concluded that telemedical DT is 
feasible because the problems that appeared were easily 
solved12 (Table 2).
Adapting to other cultures and populations
DT has been largely explored in the Anglo-Saxon contexts 
of the United States, Canada, Australia and the United 
Kingdom. In studies on adapting the therapy to other cul-
tures, some have noted cultural influences that may require 
an adaptation on the way that the therapy is offered.8,28,34 
Such differences do not mean that the therapy is not appli-
cable, but rather that it needs some adjustments in its 
application.28
On the one hand, different cultures interpret and accept 
certain words differently. There are terms that can be mis-
interpreted, such as ‘alive’, ‘more alive’, ‘still’ and ‘future’ 
and others, such as ‘proud of’, are just inappropriate in 
some cultures.14 Some of these words, for example, ‘proud 
of’, can be revised to ‘happy with’,14 to avoid conflict with 
cultural traits of modesty and privacy.28 Some reactions 
suggest that confrontations exist between the participants’ 
norms and values at the cultural, hierarchical and individ-
ual levels.34 On the other hand, the way that a population 
faces terminal condition can in itself be an obstacle for 
adapting the therapy because in the Japanese population, 
being ‘unaware of death’ is considered culturally appropri-
ate. If participating in DT is offered in a way that confronts 
them with death and dying, it is likely to be rejected.35 So, 
creating a legacy is not something patients hope for, as 
they avoid talking about their situation.8
There are studies that show DT’s adaptability among 
populations other than cancer, including the elderly popu-
lation,20,25 cognitively impaired patients;18 patients with 
ALS26,27,31 and patients with early-state dementia.32 Elderly 
participants indicated that DT positively impacts their 
experience during their final days, and that of their fami-
lies, and would recommend it to other families.18,20 
However, difficulties with patients’ cognition levels were 
seen; since DT requires memory, many patients relied on 
help from their families.18,20 In this case, DT was adapted 
to use family members as proxy informants. In response, 
researches have proposed amending the protocol in cases 
where the family participates20 and continuing to study the 
feasibility of the therapy in the elderly population.18
On the other hand, studies about DT’s suitability for 
ALS patients have been conducted.26,27,31 DT was adminis-
tered in this case with family support. There, family 
accompanied patients during sessions and participated 
when the patient requested help. The studies conclude that 
DT is suitable and beneficial and, therefore, can be adapted 
to such patients. However, these two studies26,27 referred to 
communication difficulties and the increased time the ses-
sions required since family presence made them longer. 
The number of sessions required to complete the DT was 
lower in the group assisted by their family26 (Table 2).
Discussion
There are five randomized control trials, and the results are 
not conclusive about the effect of DT on anxiety, depres-
sion, well-being, distress related to patient’s dignity, hope, 
quality of life and symptoms. Two randomized control 
trials have been conducted with patients with high levels 
of baseline psychological distress.11,29 One showed sta-
tistically significant decrease on patients’ anxiety and 
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depression scores measured at 4, 15 and 30 days, compared 
with baseline scores.29 The other comparing measurements 
pre–post DT showed statistical decrease in anxiety scores 
but not in depression.11 Regarding randomised control tri-
als with patients with low base levels of distress, measures 
of depression, distress or hope improved, albeit not signifi-
cantly. Non-randomized studies reported statistically sig-
nificant improvements on existential and psychosocial 
measurements, such as suffering and depression;13,25 
except for one study that reported increases in depression 
and anxiety scores, based on information from four 
patients9 (Table 2).
Studies that did not obtain significant results provide a 
variety of possible explanations.12,15,16,24,28,31 On the one 
hand, there is reference to the absence of a specific instru-
ment to measure the effectiveness of DT in the literature.36 
The disease’s progression may also influence the percep-
tion of the therapy’s effectiveness. As patients deteriorate, 
they may start to feel worse, and thus, their perception of 
DT’s effectiveness may not endure.13
On the other hand, sampling patients with low levels of 
distress may be the reason why studies show little impact 
from DT, given there is little room for improvement, that 
is, floor effects. Recent studies suggest the idea that 
patients with higher levels of distress may obtain more 
benefit from DT11,29 than those with low levels.
The overall results on effectiveness are in line with a 
recently published review about DT based on one database 
search including DT studies conducted with different types 
of patients,37 not just patients with life-threating advanced 
illnesses. They considered the primary results of DT on 
patients. However, the current review has included recent 
RCTs and also families and health professionals’ perspec-
tives and has carried out a critical analysis. As several 
authors mention, DT’s effect might be multidimensional 
and other possible effects of therapy should be assessed. 
Thus, a comprehensive view is needed. This idea is con-
sistent with other studies that indicate that patients, fami-
lies and healthcare professionals report that DT heightens 
a sense of dignity, hope and sense of purpose and helps 
them to know the person better13,16,22,30 (Table 2). They 
also report that it is useful for their families and offers 
opportunities to share things.23
Relatives considered that DT helped their loved one 
and increased their perception of dignity and meaning in 
life and decreased suffering.31 Family members high-
lighted the opportunity DT offers to communicate and get 
to know new parts of their lives.20
The legacy document is especially relevant for both the 
patient and his family and for professional caregivers. 
Patients and relatives suggest that DT and the legacy docu-
ment help them to share and make sense of things and also 
suggest that it will be useful when the family is mourning. 
In turn, healthcare professionals note that reading the 
patient’s legacy document helps them better understand 
the person they are caring for, has a positive effect on how 
they provide care as well as on how they assess the patient 
and it increases their satisfaction at work.18,25 However, 
some also suggest the necessity of taking into account the 
family situation, its relationship and dynamics so that DT 
does not negatively impact those.26 The protocol in fact 
provides clear directions on how family distress can be 
mitigated by taking steps to address any content that could 
provoke it.38
This review includes information about adaptations of 
DT to patients with different pathologies and in different 
cultural contexts for where it was originally developed. 
Regarding the study’s acceptability and feasibility, DT is 
seen in a positive light, but there are challenges in applying 
the therapy to patients with cognitive impairment,18,34 
fragile patients34 or people with ALS.27 Studies have 
adapted the protocol and encouraged relatives’ participa-
tion in these cases. However, in the future, it is important 
to identify which patients are most suitable for DT and 
to pinpoint adaptations needed for using DT in other 
populations.
DT adaptation studies show that this therapy is applica-
ble in different cultural contexts and in different locations 
and types of patients,14,18,25,27,31 with small protocol 
changes. For example, sometimes there are words, phrases 
or concepts that are inappropriate to the context and should 
be reconsidered.8,14,34 We should not forget that the ques-
tion framework is meant to guide the direction that the 
conversation takes; which is why flexibility is so embed-
ded within DT protocol and should be considered when 
adapting it in different contexts.
There are few publications on effective psychological 
interventions during PC treatment and those in circulation 
are limited to very specific issues, while others are too 
complex to apply clinically, which sometimes limits their 
usefulness for patients facing death with advanced disease 
and multiple symptoms. DT is a simple intervention that 
recognizes an individual’s need to have closure and 
improve communication with loved ones.37 Based on the 
evidence, DT should be offered as a choice to patients with 
life-threatening diseases and explore more deeply DT 
effect on patients and their families.
Future research should aim to define the characteris-
tics that make patients suitable for DT, focusing on iden-
tifying those who would benefit most from it. Further 
studies are necessary in patients with high levels of dis-
tress and to assess whether it is possible to demonstrate 
DT’s effectiveness in these patients. These studies should 
present sample size and statistical power calculations and 
explain clearly the randomisation process and who con-
ducts the DT and how.
It is also advisable to study ways of measuring DT’s 
effectiveness since the available instruments do not seem 
to effectively capture the intervention’s outcomes, espe-
cially given that interviews with patients and families 
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frequently reveal high levels of satisfaction and a sense 
that the therapy is useful and effective.
Limitations
One limitation found in this review is related to the pos-
sibility of publication bias since there is a tendency not 
to publish unfavourable data. In psychological interven-
tions, not being able to find significant data or differ-
ences is common for various reasons, such as a lack of 
specific instruments to measure an intervention’s effec-
tiveness which may affect effect size, the heterogeneity 
of groups or the beneficial nature of the therapist–patient 
relationship itself, which can make it difficult to pinpoint 
what exactly has been effective. On the other hand, data 
extraction was difficult in some articles since the text and 
tables did not display all quantitative information. In this 
sense, in spite of the good data collected, more detailed 
methodological information is required in some of 
the articles identified (e.g. sample size calculations, sta-
tistical power and theoretical framework for analysis in 
qualitative studies) in order to facilitate the interpretation 
of the results. This should be taken into account when 
developing future studies on DT. Furthermore, more in-
depth analysis such as multivariable analysis could be 
done in order to identify factors that might influence the 
effect of DT. The lack of homogeneity presenting the 
data complicates the comparison between studies; more 
homogeneity could facilitate new studies comparing 
populations, for example, through meta-analysis which 
could contribute to improve the evidence in the field.
It is noteworthy that majority of the studies do not 
provide detailed information about how DT was con-
ducted and therapists’ skills. Most articles include 
directly Chochinov’s protocol reference with no addi-
tional information about how it was conducted, prevent-
ing an assessment of DT protocol application which 
might influence the results.
Strengths
In this comprehensive systematic review of DT’s imple-
mentation with patients suffering from a life-threatening 
disease, we have reviewed all the results obtained from all 
DT studies meeting our defined quality threshold criteria. 
The articles have been assessed according to methodo-
logical issues and these have been considered when writ-
ing the results. Methodological shortcomings have been 
identified and reported in this comprehensive review.
The review includes an integrated and comprehensive 
view of the therapy, analysing efficiency, effectiveness, 
acceptability and feasibility, family members’ percep-
tions, as well as those of healthcare professionals, and 
the therapy’s adaptability to different populations and 
cultures.
Conclusion
The available evidence suggests that DT is beneficial. 
Patients and families evaluate it positively, suggesting that 
it has a variety of effects and can go beyond traditionally 
considered variables (e.g. anxiety or depression). The 
results suggest that patients with the highest distress levels 
can benefit the most from therapy, but more studies are 
needed to confirm DT’s outcomes. DT can be adapted to 
different populations.
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